Fc epsilon receptor (FCERI) signaling (Homo sapiens)
From WikiPathways
Description
The first step in FCERI signaling is the phosphorylation of the tyrosine residues in the ITAM of both the beta and the gamma subunits of the FCERI by LYN, which is bound to the FCERI beta-chain. The phosphorylated ITAM then recruits the protein tyrosine kinase SYK (spleen tyrosine kinase) which then phosphorylates the adaptor protein LAT. Phosphorylated LAT (linker for activation of T cells) acts as a scaffolding protein and recruits other cytosolic adaptor molecules GRB2 (growth-factor-receptor-bound protein 2), GADS (GRB2-related adaptor protein), SHC (SRC homology 2 (SH2)-domain-containing transforming protein C) and SLP76 (SH2-domain-containing leukocyte protein of 76 kDa), as well as the exchange factors and adaptor molecules VAV and SOS (son of sevenless homologue), and the signalling enzyme phospholipase C gamma1 (PLC-gamma1). Tyrosoine phosphorylation of enzymes and adaptors, including VAV, SHC GRB2 and SOS stimulate small GTPases such as RAC, RAS and RAF. These pathways lead to activation of the ERK, JNK and p38 MAP kinases, histamine release and cytokine production. FCERI activation also triggers the phosphorylation of PLC-gamma which upon membrane localisation hydrolyse PIP2 to form IP3 and 1,2-diacylglycerol (DAG) - second messengers that release Ca2+ from internal stores and activate PKC, respectively. Degranulation or histamine release follows the activation of PLC-gamma and protein kinase C (PKC) and the increased mobilization of calcium (Ca2+). Receptor aggregation also results in the phosphorylation of adaptor protein NTAL/LAT2 which then recruits GAB2. PI3K associates with phosphorylated GAB2 and catalyses the formation of PIP3 in the membrane, which attracts many PH domain proteins like BTK, PLC-gamma, AKT and PDK. PI3K mediated activation of AKT then regulate the mast cell proliferation, development and survival (Gu et al. 2001). Original Pathway at Reactome: http://www.reactome.org/PathwayBrowser/#DB=gk_current&FOCUS_SPECIES_ID=48887&FOCUS_PATHWAY_ID=2454202
Quality Tags
Ontology Terms
Bibliography
View all... |
- Roskoski R.; ''RAF protein-serine/threonine kinases: structure and regulation.''; PubMed Europe PMC Scholia
- Turjanski AG, Vaqué JP, Gutkind JS.; ''MAP kinases and the control of nuclear events.''; PubMed Europe PMC Scholia
- Yablonski D, Kadlecek T, Weiss A.; ''Identification of a phospholipase C-gamma1 (PLC-gamma1) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-gamma1 and NFAT.''; PubMed Europe PMC Scholia
- Shen X, Li H, Ou Y, Tao W, Dong A, Kong J, Ji C, Yu S.; ''The secondary structure of calcineurin regulatory region and conformational change induced by calcium/calmodulin binding.''; PubMed Europe PMC Scholia
- Reeve JL, Zou W, Liu Y, Maltzman JS, Ross FP, Teitelbaum SL.; ''SLP-76 couples Syk to the osteoclast cytoskeleton.''; PubMed Europe PMC Scholia
- Bubeck Wardenburg J, Fu C, Jackman JK, Flotow H, Wilkinson SE, Williams DH, Johnson R, Kong G, Chan AC, Findell PR.; ''Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function.''; PubMed Europe PMC Scholia
- Spencer E, Jiang J, Chen ZJ.; ''Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP.''; PubMed Europe PMC Scholia
- Zhang W, Trible RP, Zhu M, Liu SK, McGlade CJ, Samelson LE.; ''Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T cell angigen receptor-mediated signaling.''; PubMed Europe PMC Scholia
- Hendricks-Taylor LR, Motto DG, Zhang J, Siraganian RP, Koretzky GA.; ''SLP-76 is a substrate of the high affinity IgE receptor-stimulated protein tyrosine kinases in rat basophilic leukemia cells.''; PubMed Europe PMC Scholia
- Bonizzi G, Karin M.; ''The two NF-kappaB activation pathways and their role in innate and adaptive immunity.''; PubMed Europe PMC Scholia
- Cui J, Zhu L, Xia X, Wang HY, Legras X, Hong J, Ji J, Shen P, Zheng S, Chen ZJ, Wang RF.; ''NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.''; PubMed Europe PMC Scholia
- Liu SK, Fang N, Koretzky GA, McGlade CJ.; ''The hematopoietic-specific adaptor protein gads functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors.''; PubMed Europe PMC Scholia
- Plotnikov A, Zehorai E, Procaccia S, Seger R.; ''The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation.''; PubMed Europe PMC Scholia
- Parrini MC, Lei M, Harrison SC, Mayer BJ.; ''Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by Cdc42 and Rac1.''; PubMed Europe PMC Scholia
- Young RM, Holowka D, Baird B.; ''A lipid raft environment enhances Lyn kinase activity by protecting the active site tyrosine from dephosphorylation.''; PubMed Europe PMC Scholia
- Roberts PJ, Der CJ.; ''Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.''; PubMed Europe PMC Scholia
- Tkaczyk C, Horejsi V, Iwaki S, Draber P, Samelson LE, Satterthwaite AB, Nahm DH, Metcalfe DD, Gilfillan AM.; ''NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and Fc epsilon RI aggregation.''; PubMed Europe PMC Scholia
- Manetz TS, Gonzalez-Espinosa C, Arudchandran R, Xirasagar S, Tybulewicz V, Rivera J.; ''Vav1 regulates phospholipase cgamma activation and calcium responses in mast cells.''; PubMed Europe PMC Scholia
- Tybulewicz VL, Ardouin L, Prisco A, Reynolds LF.; ''Vav1: a key signal transducer downstream of the TCR.''; PubMed Europe PMC Scholia
- Rusnak F, Mertz P.; ''Calcineurin: form and function.''; PubMed Europe PMC Scholia
- Blank U, Rivera J.; ''The ins and outs of IgE-dependent mast-cell exocytosis.''; PubMed Europe PMC Scholia
- Lu W, Mayer BJ.; ''Mechanism of activation of Pak1 kinase by membrane localization.''; PubMed Europe PMC Scholia
- Latres E, Chiaur DS, Pagano M.; ''The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin.''; PubMed Europe PMC Scholia
- Krappmann D, Hatada EN, Tegethoff S, Li J, Klippel A, Giese K, Baeuerle PA, Scheidereit C.; ''The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component.''; PubMed Europe PMC Scholia
- Häcker H, Karin M.; ''Regulation and function of IKK and IKK-related kinases.''; PubMed Europe PMC Scholia
- Cuenda A, Dorow DS.; ''Differential activation of stress-activated protein kinase kinases SKK4/MKK7 and SKK1/MKK4 by the mixed-lineage kinase-2 and mitogen-activated protein kinase kinase (MKK) kinase-1.''; PubMed Europe PMC Scholia
- Matsuda M, Paterson HF, Rodriguez R, Fensome AC, Ellis MV, Swann K, Katan M.; ''Real time fluorescence imaging of PLC gamma translocation and its interaction with the epidermal growth factor receptor.''; PubMed Europe PMC Scholia
- Loh C, Shaw KT, Carew J, Viola JP, Luo C, Perrino BA, Rao A.; ''Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity.''; PubMed Europe PMC Scholia
- DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M.; ''A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.''; PubMed Europe PMC Scholia
- Roskoski R.; ''ERK1/2 MAP kinases: structure, function, and regulation.''; PubMed Europe PMC Scholia
- Peng Q, Malhotra S, Torchia JA, Kerr WG, Coggeshall KM, Humphrey MB.; ''TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.''; PubMed Europe PMC Scholia
- Gross BS, Lee JR, Clements JL, Turner M, Tybulewicz VL, Findell PR, Koretzky GA, Watson SP.; ''Tyrosine phosphorylation of SLP-76 is downstream of Syk following stimulation of the collagen receptor in platelets.''; PubMed Europe PMC Scholia
- Wellbrock C, Karasarides M, Marais R.; ''The RAF proteins take centre stage.''; PubMed Europe PMC Scholia
- Nishida K, Yamasaki S, Hasegawa A, Iwamatsu A, Koseki H, Hirano T.; ''Gab2, via PI-3K, regulates ARF1 in FcεRI-mediated granule translocation and mast cell degranulation.''; PubMed Europe PMC Scholia
- Dong W, Liu Y, Peng J, Chen L, Zou T, Xiao H, Liu Z, Li W, Bu Y, Qi Y.; ''The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4.''; PubMed Europe PMC Scholia
- Brown MD, Sacks DB.; ''Protein scaffolds in MAP kinase signalling.''; PubMed Europe PMC Scholia
- Davis RJ.; ''MAPKs: new JNK expands the group.''; PubMed Europe PMC Scholia
- Song JS, Haleem-Smith H, Arudchandran R, Gomez J, Scott PM, Mill JF, Tan TH, Rivera J.; ''Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.''; PubMed Europe PMC Scholia
- Altman A, Villalba M.; ''Protein kinase C-theta (PKC theta): a key enzyme in T cell life and death.''; PubMed Europe PMC Scholia
- Kroll M, Conconi M, Desterro MJ, Marin A, Thomas D, Friguet B, Hay RT, Virelizier JL, Arenzana-Seisdedos F, Rodriguez MS.; ''The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome.''; PubMed Europe PMC Scholia
- Alvarez-Errico D, Lessmann E, Rivera J.; ''Adapters in the organization of mast cell signaling.''; PubMed Europe PMC Scholia
- Dennler S, Prunier C, Ferrand N, Gauthier JM, Atfi A.; ''c-Jun inhibits transforming growth factor beta-mediated transcription by repressing Smad3 transcriptional activity.''; PubMed Europe PMC Scholia
- Cseh B, Doma E, Baccarini M.; ''"RAF" neighborhood: protein-protein interaction in the Raf/Mek/Erk pathway.''; PubMed Europe PMC Scholia
- Qiu L, Dhe-Paganon S.; ''Oligomeric structure of the MALT1 tandem Ig-like domains.''; PubMed Europe PMC Scholia
- Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y.; ''Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.''; PubMed Europe PMC Scholia
- Jabril-Cuenod B, Zhang C, Scharenberg AM, Paolini R, Numerof R, Beaven MA, Kinet JP.; ''Syk-dependent phosphorylation of Shc. A potential link between FcepsilonRI and the Ras/mitogen-activated protein kinase signaling pathway through SOS and Grb2.''; PubMed Europe PMC Scholia
- Iwaki S, Spicka J, Tkaczyk C, Jensen BM, Furumoto Y, Charles N, Kovarova M, Rivera J, Horejsi V, Metcalfe DD, Gilfillan AM.; ''Kit- and Fc epsilonRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility in its scaffolding function in mast cells.''; PubMed Europe PMC Scholia
- Chardin P, Camonis JH, Gale NW, van Aelst L, Schlessinger J, Wigler MH, Bar-Sagi D.; ''Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2.''; PubMed Europe PMC Scholia
- Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O, Akira S.; ''Essential function for the kinase TAK1 in innate and adaptive immune responses.''; PubMed Europe PMC Scholia
- Melowic HR, Stahelin RV, Blatner NR, Tian W, Hayashi K, Altman A, Cho W.; ''Mechanism of diacylglycerol-induced membrane targeting and activation of protein kinase Ctheta.''; PubMed Europe PMC Scholia
- Okazaki K, Sagata N.; ''The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells.''; PubMed Europe PMC Scholia
- Lennartsson J, Blume-Jensen P, Hermanson M, Pontén E, Carlberg M, Rönnstrand L.; ''Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction.''; PubMed Europe PMC Scholia
- Wang X, Chuang HC, Li JP, Tan TH.; ''Regulation of PKC-θ function by phosphorylation in T cell receptor signaling.''; PubMed Europe PMC Scholia
- Chong C, Tan L, Lim L, Manser E.; ''The mechanism of PAK activation. Autophosphorylation events in both regulatory and kinase domains control activity.''; PubMed Europe PMC Scholia
- Siraganian RP.; ''Mast cell signal transduction from the high-affinity IgE receptor.''; PubMed Europe PMC Scholia
- Hayden MS, Ghosh S.; ''Signaling to NF-kappaB.''; PubMed Europe PMC Scholia
- Oeckinghaus A, Wegener E, Welteke V, Ferch U, Arslan SC, Ruland J, Scheidereit C, Krappmann D.; ''Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation.''; PubMed Europe PMC Scholia
- Paz PE, Wang S, Clarke H, Lu X, Stokoe D, Abo A.; ''Mapping the Zap-70 phosphorylation sites on LAT (linker for activation of T cells) required for recruitment and activation of signalling proteins in T cells.''; PubMed Europe PMC Scholia
- Nore BF, Mattsson PT, Antonsson P, Bäckesjö CM, Westlund A, Lennartsson J, Hansson H, Löw P, Rönnstrand L, Smith CI.; ''Identification of phosphorylation sites within the SH3 domains of Tec family tyrosine kinases.''; PubMed Europe PMC Scholia
- Lamothe B, Besse A, Campos AD, Webster WK, Wu H, Darnay BG.; ''Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.''; PubMed Europe PMC Scholia
- Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ.; ''The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.''; PubMed Europe PMC Scholia
- Deacon K, Blank JL.; ''Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo.''; PubMed Europe PMC Scholia
- Fukumoto T, Kubota Y, Kitanaka A, Yamaoka G, Ohara-Waki F, Imataki O, Ohnishi H, Ishida T, Tanaka T.; ''Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells.''; PubMed Europe PMC Scholia
- Zhao ZS, Manser E.; ''PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.''; PubMed Europe PMC Scholia
- Vanhaesebroeck B, Alessi DR.; ''The PI3K-PDK1 connection: more than just a road to PKB.''; PubMed Europe PMC Scholia
- Wei SJ, Williams JG, Dang H, Darden TA, Betz BL, Humble MM, Chang FM, Trempus CS, Johnson K, Cannon RE, Tennant RW.; ''Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation.''; PubMed Europe PMC Scholia
- Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ.; ''TAK1 is a ubiquitin-dependent kinase of MKK and IKK.''; PubMed Europe PMC Scholia
- Wu J, Motto DG, Koretzky GA, Weiss A.; ''Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation.''; PubMed Europe PMC Scholia
- Chen TY, Illing M, Molday LL, Hsu YT, Yau KW, Molday RS.; ''Subunit 2 (or beta) of retinal rod cGMP-gated cation channel is a component of the 240-kDa channel-associated protein and mediates Ca(2+)-calmodulin modulation.''; PubMed Europe PMC Scholia
- Kim YJ, Sekiya F, Poulin B, Bae YS, Rhee SG.; ''Mechanism of B-cell receptor-induced phosphorylation and activation of phospholipase C-gamma2.''; PubMed Europe PMC Scholia
- Park H, Wahl MI, Afar DE, Turck CW, Rawlings DJ, Tam C, Scharenberg AM, Kinet JP, Witte ON.; ''Regulation of Btk function by a major autophosphorylation site within the SH3 domain.''; PubMed Europe PMC Scholia
- Liu Y, Graham C, Li A, Fisher RJ, Shaw S.; ''Phosphorylation of the protein kinase C-theta activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phosphorylation is critical to in vivo nuclear-factor-kappaB induction.''; PubMed Europe PMC Scholia
- Rhee SG.; ''Regulation of phosphoinositide-specific phospholipase C.''; PubMed Europe PMC Scholia
- Holowka D, Sil D, Torigoe C, Baird B.; ''Insights into immunoglobulin E receptor signaling from structurally defined ligands.''; PubMed Europe PMC Scholia
- Carter RS, Geyer BC, Xie M, Acevedo-Suárez CA, Ballard DW.; ''Persistent activation of NF-kappa B by the tax transforming protein involves chronic phosphorylation of IkappaB kinase subunits IKKbeta and IKKgamma.''; PubMed Europe PMC Scholia
- Garman SC, Wurzburg BA, Tarchevskaya SS, Kinet JP, Jardetzky TS.; ''Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha.''; PubMed Europe PMC Scholia
- Shiue L, Green J, Green OM, Karas JL, Morgenstern JP, Ram MK, Taylor MK, Zoller MJ, Zydowsky LD, Bolen JB.; ''Interaction of p72syk with the gamma and beta subunits of the high-affinity receptor for immunoglobulin E, Fc epsilon RI.''; PubMed Europe PMC Scholia
- Donella-Deana A, Cesaro L, Ruzzene M, Brunati AM, Marin O, Pinna LA.; ''Spontaneous autophosphorylation of Lyn tyrosine kinase at both its activation segment and C-terminal tail confers altered substrate specificity.''; PubMed Europe PMC Scholia
- Kishimoto K, Matsumoto K, Ninomiya-Tsuji J.; ''TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop.''; PubMed Europe PMC Scholia
- Gilmore TD.; ''Introduction to NF-kappaB: players, pathways, perspectives.''; PubMed Europe PMC Scholia
- Jiang Y, Cheng H.; ''Evidence of LAT as a dual substrate for Lck and Syk in T lymphocytes.''; PubMed Europe PMC Scholia
- Kanayama A, Seth RB, Sun L, Ea CK, Hong M, Shaito A, Chiu YH, Deng L, Chen ZJ.; ''TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains.''; PubMed Europe PMC Scholia
- Thuille N, Heit I, Fresser F, Krumböck N, Bauer B, Leuthaeusser S, Dammeier S, Graham C, Copeland TD, Shaw S, Baier G.; ''Critical role of novel Thr-219 autophosphorylation for the cellular function of PKCtheta in T lymphocytes.''; PubMed Europe PMC Scholia
- Bos JL, Rehmann H, Wittinghofer A.; ''GEFs and GAPs: critical elements in the control of small G proteins.''; PubMed Europe PMC Scholia
- Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Irvin BJ, Zhang W, Samelson LE, Abraham RT, Leibson PJ.; ''Cutting edge: a role for the adaptor protein LAT in human NK cell-mediated cytotoxicity.''; PubMed Europe PMC Scholia
- Hogan PG, Chen L, Nardone J, Rao A.; ''Transcriptional regulation by calcium, calcineurin, and NFAT.''; PubMed Europe PMC Scholia
- Dinh M, Grunberger D, Ho H, Tsing SY, Shaw D, Lee S, Barnett J, Hill RJ, Swinney DC, Bradshaw JM.; ''Activation mechanism and steady state kinetics of Bruton's tyrosine kinase.''; PubMed Europe PMC Scholia
- Baldi L, Brown K, Franzoso G, Siebenlist U.; ''Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I kappa B-alpha.''; PubMed Europe PMC Scholia
- Roskoski R.; ''MEK1/2 dual-specificity protein kinases: structure and regulation.''; PubMed Europe PMC Scholia
- Carter RS, Pennington KN, Ungurait BJ, Arrate P, Ballard DW.; ''Signal-induced ubiquitination of I kappaB Kinase-beta.''; PubMed Europe PMC Scholia
- Mizukami Y, Yoshioka K, Morimoto S, Yoshida Ki.; ''A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion.''; PubMed Europe PMC Scholia
- Parrini MC, Camonis J, Matsuda M, de Gunzburg J.; ''Dissecting activation of the PAK1 kinase at protrusions in living cells.''; PubMed Europe PMC Scholia
- Yu M, Lowell CA, Neel BG, Gu H.; ''Scaffolding adapter Grb2-associated binder 2 requires Syk to transmit signals from FcepsilonRI.''; PubMed Europe PMC Scholia
- Aghazadeh B, Lowry WE, Huang XY, Rosen MK.; ''Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation.''; PubMed Europe PMC Scholia
- Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA.; ''Mutations of the BRAF gene in human cancer.''; PubMed Europe PMC Scholia
- Rothwarf DM, Zandi E, Natoli G, Karin M.; ''IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex.''; PubMed Europe PMC Scholia
- Vonakis BM, Chen H, Haleem-Smith H, Metzger H.; ''The unique domain as the site on Lyn kinase for its constitutive association with the high affinity receptor for IgE.''; PubMed Europe PMC Scholia
- Park S, Uesugi M, Verdine GL.; ''A second calcineurin binding site on the NFAT regulatory domain.''; PubMed Europe PMC Scholia
- Tanner MJ, Hanel W, Gaffen SL, Lin X.; ''CARMA1 coiled-coil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T cell receptor-induced NF-kappaB activation.''; PubMed Europe PMC Scholia
- Harmer SL, DeFranco AL.; ''Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes.''; PubMed Europe PMC Scholia
- Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J.; ''Molecular interpretation of ERK signal duration by immediate early gene products.''; PubMed Europe PMC Scholia
- Shambharkar PB, Blonska M, Pappu BP, Li H, You Y, Sakurai H, Darnay BG, Hara H, Penninger J, Lin X.; ''Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathways.''; PubMed Europe PMC Scholia
- Raivich G.; ''c-Jun expression, activation and function in neural cell death, inflammation and repair.''; PubMed Europe PMC Scholia
- Adhikari A, Xu M, Chen ZJ.; ''Ubiquitin-mediated activation of TAK1 and IKK.''; PubMed Europe PMC Scholia
- Cantwell-Dorris ER, O'Leary JJ, Sheils OM.; ''BRAFV600E: implications for carcinogenesis and molecular therapy.''; PubMed Europe PMC Scholia
- Teramoto H, Salem P, Robbins KC, Bustelo XR, Gutkind JS.; ''Tyrosine phosphorylation of the vav proto-oncogene product links FcepsilonRI to the Rac1-JNK pathway.''; PubMed Europe PMC Scholia
- Okamura H, Aramburu J, García-Rodríguez C, Viola JP, Raghavan A, Tahiliani M, Zhang X, Qin J, Hogan PG, Rao A.; ''Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity.''; PubMed Europe PMC Scholia
- Whitman M, Downes CP, Keeler M, Keller T, Cantley L.; ''Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate.''; PubMed Europe PMC Scholia
- Boriack-Sjodin PA, Margarit SM, Bar-Sagi D, Kuriyan J.; ''The structural basis of the activation of Ras by Sos.''; PubMed Europe PMC Scholia
- Allen JD, Jaffer ZM, Park SJ, Burgin S, Hofmann C, Sells MA, Chen S, Derr-Yellin E, Michels EG, McDaniel A, Bessler WK, Ingram DA, Atkinson SJ, Travers JB, Chernoff J, Clapp DW.; ''p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics.''; PubMed Europe PMC Scholia
- Manicassamy S, Gupta S, Sun Z.; ''Selective function of PKC-theta in T cells.''; PubMed Europe PMC Scholia
- Rueda D, Thome M.; ''Phosphorylation of CARMA1: the link(er) to NF-kappaB activation.''; PubMed Europe PMC Scholia
- McKay MM, Morrison DK.; ''Integrating signals from RTKs to ERK/MAPK.''; PubMed Europe PMC Scholia
- Asada H, Ishii N, Sasaki Y, Endo K, Kasai H, Tanaka N, Takeshita T, Tsuchiya S, Konno T, Sugamura K.; ''Grf40, A novel Grb2 family member, is involved in T cell signaling through interaction with SLP-76 and LAT.''; PubMed Europe PMC Scholia
- Wen R, Jou ST, Chen Y, Hoffmeyer A, Wang D.; ''Phospholipase C gamma 2 is essential for specific functions of Fc epsilon R and Fc gamma R.''; PubMed Europe PMC Scholia
- Uren AG, O'Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, Koonin EV, Dixit VM.; ''Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma.''; PubMed Europe PMC Scholia
- Sakurai H, Miyoshi H, Mizukami J, Sugita T.; ''Phosphorylation-dependent activation of TAK1 mitogen-activated protein kinase kinase kinase by TAB1.''; PubMed Europe PMC Scholia
- Yan M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR, Templeton DJ.; ''Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1.''; PubMed Europe PMC Scholia
- Deckert M, Tartare-Deckert S, Couture C, Mustelin T, Altman A.; ''Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product.''; PubMed Europe PMC Scholia
- Kovárová M, Tolar P, Arudchandran R, Dráberová L, Rivera J, Dráber P.; ''Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcepsilon receptor I aggregation.''; PubMed Europe PMC Scholia
- Glover JN, Harrison SC.; ''Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA.''; PubMed Europe PMC Scholia
- Pribluda VS, Pribluda C, Metzger H.; ''Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation.''; PubMed Europe PMC Scholia
- Sebban-Benin H, Pescatore A, Fusco F, Pascuale V, Gautheron J, Yamaoka S, Moncla A, Ursini MV, Courtois G.; ''Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti.''; PubMed Europe PMC Scholia
- Takeuchi K, Roehrl MH, Sun ZY, Wagner G.; ''Structure of the calcineurin-NFAT complex: defining a T cell activation switch using solution NMR and crystal coordinates.''; PubMed Europe PMC Scholia
- Yang YJ, Chen W, Carrigan SO, Chen WM, Roth K, Akiyama T, Inoue J, Marshall JS, Berman JN, Lin TJ.; ''TRAF6 specifically contributes to FcepsilonRI-mediated cytokine production but not mast cell degranulation.''; PubMed Europe PMC Scholia
- Kyriakis JM, Avruch J.; ''Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update.''; PubMed Europe PMC Scholia
- Dráber P, Dráberová L.; ''Lipid rafts in mast cell signaling.''; PubMed Europe PMC Scholia
- Lutz C, Nimpf J, Jenny M, Boecklinger K, Enzinger C, Utermann G, Baier-Bitterlich G, Baier G.; ''Evidence of functional modulation of the MEKK/JNK/cJun signaling cascade by the low density lipoprotein receptor-related protein (LRP).''; PubMed Europe PMC Scholia
- Cargnello M, Roux PP.; ''Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.''; PubMed Europe PMC Scholia
- Thome M, Charton JE, Pelzer C, Hailfinger S.; ''Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.''; PubMed Europe PMC Scholia
- Liu Y, Graham C, Parravicini V, Brown MJ, Rivera J, Shaw S.; ''Protein kinase C theta is expressed in mast cells and is functionally involved in Fcepsilon receptor I signaling.''; PubMed Europe PMC Scholia
- Besse A, Lamothe B, Campos AD, Webster WK, Maddineni U, Lin SC, Wu H, Darnay BG.; ''TAK1-dependent signaling requires functional interaction with TAB2/TAB3.''; PubMed Europe PMC Scholia
- Kihara H, Siraganian RP.; ''Src homology 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunits of the high affinity IgE receptor.''; PubMed Europe PMC Scholia
- Luo C, Shaw KT, Raghavan A, Aramburu J, Garcia-Cozar F, Perrino BA, Hogan PG, Rao A.; ''Interaction of calcineurin with a domain of the transcription factor NFAT1 that controls nuclear import.''; PubMed Europe PMC Scholia
- Voges D, Zwickl P, Baumeister W.; ''The 26S proteasome: a molecular machine designed for controlled proteolysis.''; PubMed Europe PMC Scholia
- Rawlings DJ, Scharenberg AM, Park H, Wahl MI, Lin S, Kato RM, Fluckiger AC, Witte ON, Kinet JP.; ''Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases.''; PubMed Europe PMC Scholia
- Sundarrajan M, Boyle DL, Chabaud-Riou M, Hammaker D, Firestein GS.; ''Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK.''; PubMed Europe PMC Scholia
- Israël A.; ''The IKK complex, a central regulator of NF-kappaB activation.''; PubMed Europe PMC Scholia
- Kimura T, Kihara H, Bhattacharyya S, Sakamoto H, Appella E, Siraganian RP.; ''Downstream signaling molecules bind to different phosphorylated immunoreceptor tyrosine-based activation motif (ITAM) peptides of the high affinity IgE receptor.''; PubMed Europe PMC Scholia
- Nishida K, Yoshida Y, Itoh M, Fukada T, Ohtani T, Shirogane T, Atsumi T, Takahashi-Tezuka M, Ishihara K, Hibi M, Hirano T.; ''Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors.''; PubMed Europe PMC Scholia
- Kim HL, Vander Griend DJ, Yang X, Benson DA, Dubauskas Z, Yoshida BA, Chekmareva MA, Ichikawa Y, Sokoloff MH, Zhan P, Karrison T, Lin A, Stadler WM, Ichikawa T, Rubin MA, Rinker-Schaeffer CW.; ''Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.''; PubMed Europe PMC Scholia
- Kawakami Y, Yao L, Miura T, Tsukada S, Witte ON, Kawakami T.; ''Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking.''; PubMed Europe PMC Scholia
- Matsumoto R, Wang D, Blonska M, Li H, Kobayashi M, Pappu B, Chen Y, Wang D, Lin X.; ''Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation.''; PubMed Europe PMC Scholia
- Koyasu S.; ''The role of PI3K in immune cells.''; PubMed Europe PMC Scholia
- Wu LC.; ''Immunoglobulin E receptor signaling and asthma.''; PubMed Europe PMC Scholia
- Chen ZJ, Parent L, Maniatis T.; ''Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity.''; PubMed Europe PMC Scholia
- Wang X, Nadarajah B, Robinson AC, McColl BW, Jin JW, Dajas-Bailador F, Boot-Handford RP, Tournier C.; ''Targeted deletion of the mitogen-activated protein kinase kinase 4 gene in the nervous system causes severe brain developmental defects and premature death.''; PubMed Europe PMC Scholia
- Ainbinder E, Bergelson S, Pinkus R, Daniel V.; ''Regulatory mechanisms involved in activator-protein-1 (AP-1)-mediated activation of glutathione-S-transferase gene expression by chemical agents.''; PubMed Europe PMC Scholia
- Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, Irie K, Ninomiya-Tsuji J, Matsumoto K.; ''TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway.''; PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
ADP | Metabolite | CHEBI:16761 (ChEBI) | |
AMP | Metabolite | CHEBI:16027 (ChEBI) | |
ATP | Metabolite | CHEBI:15422 (ChEBI) | |
Active Calmodulin | Complex | REACT_3178 (Reactome) | |
Allergin
p-LYN p-FCERI IgE aggregate | Complex | REACT_165244 (Reactome) | |
Allergin | REACT_164121 (Reactome) | ||
BCL10 MALT1 | Complex | REACT_165506 (Reactome) | |
BCL10 | Protein | O95999 (Uniprot-TrEMBL) | |
BCL10 | Protein | O95999 (Uniprot-TrEMBL) | |
CALM1 | Protein | P62158 (Uniprot-TrEMBL) | |
CALM1 | Protein | P62158 (Uniprot-TrEMBL) | |
CARD11 | Protein | Q9BXL7 (Uniprot-TrEMBL) | |
CHUK | Protein | O15111 (Uniprot-TrEMBL) | |
Ca2+ | Metabolite | CHEBI:29108 (ChEBI) | |
Ca2+ | Metabolite | CHEBI:29108 (ChEBI) | |
Calcineurin Calmodulin | Complex | REACT_119482 (Reactome) | |
Calcineurin | Complex | REACT_119672 (Reactome) | |
Clustered p
LYN p-FCERI IgE allergin SYK | Complex | REACT_165178 (Reactome) | |
Clustered p
LYN p-FCERI IgE allergin p-6Y-SYK | Complex | REACT_165068 (Reactome) | |
DAG
p-5Y-PKC-theta CBM complex | Complex | REACT_165355 (Reactome) | |
DAG
p-5Y-PKC-theta CBM oligomer TRAF6 oligomer | Complex | REACT_164024 (Reactome) | |
DAG
p-5Y-PKC-theta CBM oligomer TRAF6 | Complex | REACT_164811 (Reactome) | |
DAG
p-5Y-PKC-theta CBM oligomer oligo-K63-poly Ub-TRAF6 TAK1 TAB1 TAB2/3 | Complex | REACT_165256 (Reactome) | |
DAG
p-5Y-PKC-theta CBM oligomer oligo-K63-poly Ub-TRAF6 activated TAK1 complex | Complex | REACT_164823 (Reactome) | |
DAG
p-5Y-PKC-theta CBM oligomer oligo-K63-poly Ub-TRAF6 | Complex | REACT_165243 (Reactome) | |
DAG
p-5Y-PKC-theta CBM oligomer | Complex | REACT_165009 (Reactome) | |
DAG
p-5Y-PKC-theta p-S552,S645-CARMA1 oligomer | Complex | REACT_164911 (Reactome) | |
DAG
p-5Y-PKC-theta p-S552,S645-CARMA1 | Complex | REACT_164769 (Reactome) | |
DAGs | Metabolite | CHEBI:18035 (ChEBI) | |
DAGs | Metabolite | CHEBI:18035 (ChEBI) | |
FCER1A | Protein | P12319 (Uniprot-TrEMBL) | |
FCER1G | Protein | P30273 (Uniprot-TrEMBL) | |
FCERI
IgE allergin aggregate | Complex | REACT_164529 (Reactome) | |
FCERI IgE | Complex | REACT_164240 (Reactome) | |
FOS | Protein | P01100 (Uniprot-TrEMBL) | |
Fe3+ | Metabolite | CHEBI:29034 (ChEBI) | |
GAB2 | Protein | Q9UQC2 (Uniprot-TrEMBL) | |
GAB2 | Protein | Q9UQC2 (Uniprot-TrEMBL) | |
GADS SLP76 | Complex | REACT_147999 (Reactome) | |
GDP | Metabolite | CHEBI:17552 (ChEBI) | |
GDP | Metabolite | CHEBI:17552 (ChEBI) | |
GRAP2 | Protein | O75791 (Uniprot-TrEMBL) | |
GRB2 SOS1 | Complex | REACT_4435 (Reactome) | |
GRB2-1 | Protein | P62993-1 (Uniprot-TrEMBL) | |
GTP | Metabolite | CHEBI:15996 (ChEBI) | |
GTP | Metabolite | CHEBI:15996 (ChEBI) | |
H2O | Metabolite | CHEBI:15377 (ChEBI) | |
HRAS | Protein | P01112 (Uniprot-TrEMBL) | |
I | Metabolite | CHEBI:16595 (ChEBI) | |
IGHE | Protein | P01854 (Uniprot-TrEMBL) | |
IGHV7-81 | Protein | Q6PIL0 (Uniprot-TrEMBL) | |
IGHV | Protein | A2KUC3 (Uniprot-TrEMBL) | |
IGKC | Protein | P01834 (Uniprot-TrEMBL) | |
IGKV1-5 | Protein | P01602 (Uniprot-TrEMBL) | |
IGKV4-1 | Protein | P06312 (Uniprot-TrEMBL) | |
IGKVA18 | Protein | A2NJV5 (Uniprot-TrEMBL) | |
IGLC1 | Protein | P0CG04 (Uniprot-TrEMBL) | |
IGLC2 | Protein | P0CG05 (Uniprot-TrEMBL) | |
IGLC3 | Protein | P0CG06 (Uniprot-TrEMBL) | |
IGLC6 | Protein | P0CF74 (Uniprot-TrEMBL) | |
IGLC7 | Protein | A0M8Q6 (Uniprot-TrEMBL) | |
IGLV1-36 | Protein | Q5NV67 (Uniprot-TrEMBL) | |
IGLV1-40 | Protein | Q5NV69 (Uniprot-TrEMBL) | |
IGLV1-44 | Protein | Q5NV81 (Uniprot-TrEMBL) | |
IGLV10-54 | Protein | Q5NV86 (Uniprot-TrEMBL) | |
IGLV11-55 | Protein | Q5NV87 (Uniprot-TrEMBL) | |
IGLV2-11 | Protein | Q5NV84 (Uniprot-TrEMBL) | |
IGLV2-18 | Protein | Q5NV65 (Uniprot-TrEMBL) | |
IGLV2-23 | Protein | Q5NV89 (Uniprot-TrEMBL) | |
IGLV2-33 | Protein | Q5NV66 (Uniprot-TrEMBL) | |
IGLV3-12 | Protein | Q5NV85 (Uniprot-TrEMBL) | |
IGLV3-16 | Protein | Q5NV64 (Uniprot-TrEMBL) | |
IGLV3-22 | Protein | Q5NV75 (Uniprot-TrEMBL) | |
IGLV3-25 | Protein | Q5NV90 (Uniprot-TrEMBL) | |
IGLV3-27 | Protein | Q5NV91 (Uniprot-TrEMBL) | |
IGLV4-3 | Protein | Q5NV61 (Uniprot-TrEMBL) | |
IGLV4-60 | Protein | Q5NV79 (Uniprot-TrEMBL) | |
IGLV4-69 | Protein | Q5NV92 (Uniprot-TrEMBL) | |
IGLV5-37 | Protein | Q5NV68 (Uniprot-TrEMBL) | |
IGLV5-45 | Protein | Q5NV82 (Uniprot-TrEMBL) | |
IGLV7-43 | Protein | Q5NV80 (Uniprot-TrEMBL) | |
IGLV7-46 | Protein | Q5NV83 (Uniprot-TrEMBL) | |
IGLV8-61 | Protein | Q5NV62 (Uniprot-TrEMBL) | |
IGLV | Protein | A2NXD2 (Uniprot-TrEMBL) | |
IKBKB | Protein | O14920 (Uniprot-TrEMBL) | |
IKBKG | Protein | Q9Y6K9 (Uniprot-TrEMBL) | |
IKKA
IKKB NEMO | Complex | REACT_7693 (Reactome) | |
IP3 receptor IP3 complex | Complex | REACT_12249 (Reactome) | |
IP3 receptor homotetramer | Complex | REACT_12247 (Reactome) | |
ITPR1 | Protein | Q14643 (Uniprot-TrEMBL) | |
ITPR2 | Protein | Q14571 (Uniprot-TrEMBL) | |
ITPR3 | Protein | Q14573 (Uniprot-TrEMBL) | |
Ig heavy chain V-I region EU | Protein | P01742 (Uniprot-TrEMBL) | |
Ig heavy chain V-I region HG3 | Protein | P01743 (Uniprot-TrEMBL) | |
Ig heavy chain V-I region Mot | Protein | P06326 (Uniprot-TrEMBL) | |
Ig heavy chain V-I region ND | Protein | P01744 (Uniprot-TrEMBL) | |
Ig heavy chain V-I region SIE | Protein | P01761 (Uniprot-TrEMBL) | |
Ig heavy chain V-I region WOL | Protein | P01760 (Uniprot-TrEMBL) | |
Ig heavy chain V-II region ARH-77 | Protein | P06331 (Uniprot-TrEMBL) | |
Ig heavy chain V-II region COR | Protein | P01815 (Uniprot-TrEMBL) | |
Ig heavy chain V-II region DAW | Protein | P01816 (Uniprot-TrEMBL) | |
Ig heavy chain V-II region HE | Protein | P01818 (Uniprot-TrEMBL) | |
Ig heavy chain V-II region MCE | Protein | P01817 (Uniprot-TrEMBL) | |
Ig heavy chain V-II region NEWM | Protein | P01825 (Uniprot-TrEMBL) | |
Ig heavy chain V-II region OU | Protein | P01814 (Uniprot-TrEMBL) | |
Ig heavy chain V-II region SESS | Protein | P04438 (Uniprot-TrEMBL) | |
Ig heavy chain V-II region WAH | Protein | P01824 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region BRO | Protein | P01766 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region BUR | Protein | P01773 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region BUT | Protein | P01767 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region CAM | Protein | P01768 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region DOB | Protein | P01782 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region GA | Protein | P01769 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region GAL | Protein | P01781 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region HIL | Protein | P01771 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region JON | Protein | P01780 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region KOL | Protein | P01772 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region LAY | Protein | P01775 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region NIE | Protein | P01770 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region POM | Protein | P01774 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region TEI | Protein | P01777 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region TIL | Protein | P01765 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region TRO | Protein | P01762 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region TUR | Protein | P01779 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region WAS | Protein | P01776 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region WEA | Protein | P01763 (Uniprot-TrEMBL) | |
Ig heavy chain V-III region ZAP | Protein | P01778 (Uniprot-TrEMBL) | |
Ig kappa chain V region EV15 | Protein | P06315 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region AG | Protein | P01593 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region AU | Protein | P01594 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region BAN | Protein | P04430 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Bi | Protein | P01595 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region CAR | Protein | P01596 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region DEE | Protein | P01597 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Daudi | Protein | P04432 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region EU | Protein | P01598 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Gal | Protein | P01599 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region HK101 | Protein | P01601 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Hau | Protein | P01600 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Ka | Protein | P01603 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Kue | Protein | P01604 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Lay | Protein | P01605 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Mev | Protein | P01612 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Ni | Protein | P01613 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region OU | Protein | P01606 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Rei | Protein | P01607 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Roy | Protein | P01608 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Scw | Protein | P01609 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region WAT | Protein | P80362 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region WEA | Protein | P01610 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Walker | Protein | P04431 (Uniprot-TrEMBL) | |
Ig kappa chain V-I region Wes | Protein | P01611 (Uniprot-TrEMBL) | |
Ig kappa chain V-II region Cum | Protein | P01614 (Uniprot-TrEMBL) | |
Ig kappa chain V-II region FR | Protein | P01615 (Uniprot-TrEMBL) | |
Ig kappa chain V-II region GM607 | Protein | P06309 (Uniprot-TrEMBL) | |
Ig kappa chain V-II region MIL | Protein | P01616 (Uniprot-TrEMBL) | |
Ig kappa chain V-II region RPMI 6410 | Protein | P06310 (Uniprot-TrEMBL) | |
Ig kappa chain V-II region TEW | Protein | P01617 (Uniprot-TrEMBL) | |
Ig kappa chain V-III region B6 | Protein | P01619 (Uniprot-TrEMBL) | |
Ig kappa chain V-III region CLL | Protein | P04207 (Uniprot-TrEMBL) | |
Ig kappa chain V-III region GOL | Protein | P04206 (Uniprot-TrEMBL) | |
Ig kappa chain V-III region HAH | Protein | P18135 (Uniprot-TrEMBL) | |
Ig kappa chain V-III region HIC | Protein | P18136 (Uniprot-TrEMBL) | |
Ig kappa chain V-III region IARC/BL41 | Protein | P06311 (Uniprot-TrEMBL) | |
Ig kappa chain V-III region NG9 | Protein | P01621 (Uniprot-TrEMBL) | |
Ig kappa chain V-III region POM | Protein | P01624 (Uniprot-TrEMBL) | |
Ig kappa chain V-III region SIE | Protein | P01620 (Uniprot-TrEMBL) | |
Ig kappa chain V-III region Ti | Protein | P01622 (Uniprot-TrEMBL) | |
Ig kappa chain V-III region VG | Protein | P04433 (Uniprot-TrEMBL) | |
Ig kappa chain V-III region VH | Protein | P04434 (Uniprot-TrEMBL) | |
Ig kappa chain V-III region WOL | Protein | P01623 (Uniprot-TrEMBL) | |
Ig kappa chain V-IV region B17 | Protein | P06314 (Uniprot-TrEMBL) | |
Ig kappa chain V-IV region JI | Protein | P06313 (Uniprot-TrEMBL) | |
Ig kappa chain V-IV region Len | Protein | P01625 (Uniprot-TrEMBL) | |
Ig kappa chain V-IV region STH | Protein | P83593 (Uniprot-TrEMBL) | |
Ig lambda chain V region 4A | Protein | P04211 (Uniprot-TrEMBL) | |
Ig lambda chain V-I region BL2 | Protein | P06316 (Uniprot-TrEMBL) | |
Ig lambda chain V-I region EPS | Protein | P06888 (Uniprot-TrEMBL) | |
Ig lambda chain V-I region HA | Protein | P01700 (Uniprot-TrEMBL) | |
Ig lambda chain V-I region MEM | Protein | P06887 (Uniprot-TrEMBL) | |
Ig lambda chain V-I region NEW | Protein | P01701 (Uniprot-TrEMBL) | |
Ig lambda chain V-I region NEWM | Protein | P01703 (Uniprot-TrEMBL) | |
Ig lambda chain V-I region NIG-64 | Protein | P01702 (Uniprot-TrEMBL) | |
Ig lambda chain V-I region VOR | Protein | P01699 (Uniprot-TrEMBL) | |
Ig lambda chain V-I region WAH | Protein | P04208 (Uniprot-TrEMBL) | |
Ig lambda chain V-II region BO | Protein | P01710 (Uniprot-TrEMBL) | |
Ig lambda chain V-II region BOH | Protein | P01706 (Uniprot-TrEMBL) | |
Ig lambda chain V-II region BUR | Protein | P01708 (Uniprot-TrEMBL) | |
Ig lambda chain V-II region MGC | Protein | P01709 (Uniprot-TrEMBL) | |
Ig lambda chain V-II region NEI | Protein | P01705 (Uniprot-TrEMBL) | |
Ig lambda chain V-II region NIG-58 | Protein | P01713 (Uniprot-TrEMBL) | |
Ig lambda chain V-II region NIG-84 | Protein | P04209 (Uniprot-TrEMBL) | |
Ig lambda chain V-II region TOG | Protein | P01704 (Uniprot-TrEMBL) | |
Ig lambda chain V-II region TRO | Protein | P01707 (Uniprot-TrEMBL) | |
Ig lambda chain V-II region VIL | Protein | P01711 (Uniprot-TrEMBL) | |
Ig lambda chain V-II region WIN | Protein | P01712 (Uniprot-TrEMBL) | |
Ig lambda chain V-III region LOI | Protein | P80748 (Uniprot-TrEMBL) | |
Ig lambda chain V-III region SH | Protein | P01714 (Uniprot-TrEMBL) | |
Ig lambda chain V-IV region Bau | Protein | P01715 (Uniprot-TrEMBL) | |
Ig lambda chain V-IV region Hil | Protein | P01717 (Uniprot-TrEMBL) | |
Ig lambda chain V-IV region Kern | Protein | P01718 (Uniprot-TrEMBL) | |
Ig lambda chain V-IV region MOL | Protein | P06889 (Uniprot-TrEMBL) | |
Ig lambda chain V-IV region X | Protein | P01716 (Uniprot-TrEMBL) | |
Ig lambda chain V-V region DEL | Protein | P01719 (Uniprot-TrEMBL) | |
Ig lambda chain V-VI region AR | Protein | P01721 (Uniprot-TrEMBL) | |
Ig lambda chain V-VI region EB4 | Protein | P06319 (Uniprot-TrEMBL) | |
Ig lambda chain V-VI region NIG-48 | Protein | P01722 (Uniprot-TrEMBL) | |
Ig lambda chain V-VI region SUT | Protein | P06317 (Uniprot-TrEMBL) | |
Ig lambda chain V-VI region WLT | Protein | P06318 (Uniprot-TrEMBL) | |
Ig lambda chain V-VII region MOT | Protein | P01720 (Uniprot-TrEMBL) | |
IgH heavy chain V-III region VH26 precursor | Protein | P01764 (Uniprot-TrEMBL) | |
IkB | Complex | REACT_12767 (Reactome) | |
JUN | Protein | P05412 (Uniprot-TrEMBL) | |
K63polyUb TRAF6 | Protein | Q9Y4K3 (Uniprot-TrEMBL) | |
K63polyUb-NEMO | Protein | Q9Y6K9 (Uniprot-TrEMBL) | |
K63polyUb | REACT_21645 (Reactome) | ||
KRAS | Protein | P01116 (Uniprot-TrEMBL) | |
LAT-2 | Protein | O43561-2 (Uniprot-TrEMBL) | |
LAT2 | Protein | Q9GZY6 (Uniprot-TrEMBL) | |
LCP2 | Protein | Q13094 (Uniprot-TrEMBL) | |
LYN | Protein | P07948 (Uniprot-TrEMBL) | |
MALT1 | Protein | Q9UDY8 (Uniprot-TrEMBL) | |
MALT1 | Protein | Q9UDY8 (Uniprot-TrEMBL) | |
MAP2K4 | Protein | P45985 (Uniprot-TrEMBL) | |
MAP2K7 | Protein | O14733 (Uniprot-TrEMBL) | |
MAP3K1 | Protein | Q13233 (Uniprot-TrEMBL) | |
MAP3K7 | Protein | O43318 (Uniprot-TrEMBL) | |
MAPK8/9/10 | Protein | REACT_21895 (Reactome) | |
MS4A2 | Protein | Q01362 (Uniprot-TrEMBL) | |
NF-kB complex | Complex | REACT_12775 (Reactome) | |
NF-kB complex | Complex | REACT_12832 (Reactome) | |
NFAT
CaN CaM | Complex | REACT_164084 (Reactome) | |
NFAT
CaN CaM | Complex | REACT_164266 (Reactome) | |
NFKB1 | Protein | P19838 (Uniprot-TrEMBL) | |
NFKBIA | Protein | P25963 (Uniprot-TrEMBL) | |
NRAS | Protein | P01111 (Uniprot-TrEMBL) | |
PAK dimer | Complex | REACT_164900 (Reactome) | |
PAK1 | Protein | Q13153 (Uniprot-TrEMBL) | |
PAK2 | Protein | Q13177 (Uniprot-TrEMBL) | |
PDK1 PIP2,PIP3 | Complex | REACT_12991 (Reactome) | |
PDPK1 | Protein | O15530 (Uniprot-TrEMBL) | |
PDPK1 | Protein | O15530 (Uniprot-TrEMBL) | |
PI3K | Complex | REACT_4240 (Reactome) | |
PI | Metabolite | CHEBI:16152 (ChEBI) | |
PI | Metabolite | CHEBI:16618 (ChEBI) | |
PI | Metabolite | CHEBI:18348 (ChEBI) | |
PIK3CA | Protein | P42336 (Uniprot-TrEMBL) | |
PIK3CB | Protein | P42338 (Uniprot-TrEMBL) | |
PIK3R1 | Protein | P27986 (Uniprot-TrEMBL) | |
PIK3R2 | Protein | O00459 (Uniprot-TrEMBL) | |
PIP3 activates AKT signaling | Pathway | WP2653 (WikiPathways) | Signaling by AKT is one of the key outcomes of receptor tyrosine kinase (RTK) activation. AKT is activated by the cellular second messenger PIP3, a phospholipid that is generated by PI3K. In ustimulated cells, PI3K class IA enzymes reside in the cytosol as inactive heterodimers composed of p85 regulatory subunit and p110 catalytic subunit. In this complex, p85 stabilizes p110 while inhibiting its catalytic activity. Upon binding of extracellular ligands to RTKs, receptors dimerize and undergo autophosphorylation. The regulatory subunit of PI3K, p85, is recruited to phosphorylated cytosolic RTK domains either directly or indirectly, through adaptor proteins, leading to a conformational change in the PI3K IA heterodimer that relieves inhibition of the p110 catalytic subunit. Activated PI3K IA phosphorylates PIP2, converting it to PIP3; this reaction is negatively regulated by PTEN phosphatase. PIP3 recruits AKT to the plasma membrane, allowing TORC2 to phosphorylate a conserved serine residue of AKT. Phosphorylation of this serine induces a conformation change in AKT, exposing a conserved threonine residue that is then phosphorylated by PDPK1 (PDK1). Phosphorylation of both the threonine and the serine residue is required to fully activate AKT. The active AKT then dissociates from PIP3 and phosphorylates a number of cytosolic and nuclear proteins that play important roles in cell survival and metabolism. For a recent review of AKT signaling, please refer to Manning and Cantley, 2007. |
PIP3, PI | Metabolite | REACT_12804 (Reactome) | |
PKC-theta | Complex | REACT_13197 (Reactome) | |
PLC gamma1/2 | Protein | REACT_120292 (Reactome) | |
PLCG1 | Protein | P19174 (Uniprot-TrEMBL) | |
PLCG2 | Protein | P16885 (Uniprot-TrEMBL) | |
PPP3CA | Protein | Q08209 (Uniprot-TrEMBL) | |
PPP3CB | Protein | P16298 (Uniprot-TrEMBL) | |
PPP3R1 | Protein | P63098 (Uniprot-TrEMBL) | |
PPi | Metabolite | CHEBI:29888 (ChEBI) | |
PRKCQ | Protein | Q04759 (Uniprot-TrEMBL) | |
PRKQC closed conformation | Protein | Q04759 (Uniprot-TrEMBL) | |
Phospho-ERK dimer | Complex | REACT_12827 (Reactome) | |
Phosphorylated NFATC1/2/3 | Protein | REACT_120227 (Reactome) | |
Pi | Metabolite | CHEBI:18367 (ChEBI) | |
RAC1 | Protein | P63000 (Uniprot-TrEMBL) | |
RAC1-GDP | Complex | REACT_22018 (Reactome) | |
RAF/MAP kinase cascade | Pathway | WP2735 (WikiPathways) | The MAP kinase cascade describes a sequence of phosphorylation events involving serine/threonine-specific protein kinases. Used by various signal transduction pathways, this cascade constitutes a common 'module' in the transmission of an extracellular signal into the nucleus. |
RELA | Protein | Q04206 (Uniprot-TrEMBL) | |
RasGRPs
DAG Ca2+ | Complex | REACT_164524 (Reactome) | |
RasGRPs | Protein | REACT_165129 (Reactome) | Rap1 can be activated by certain GEFs that respond to calcium and diacylglycerol (CalDAG-GEFs). |
SHC1-2 | Protein | P29353-2 (Uniprot-TrEMBL) | |
SOS1 | Protein | Q07889 (Uniprot-TrEMBL) | |
SYK | Protein | P43405 (Uniprot-TrEMBL) | |
SYK/FYN | Complex | REACT_164115 (Reactome) | |
SYK | Protein | P43405 (Uniprot-TrEMBL) | |
TAB1
TAB2/TAB3 TAK1 | Complex | REACT_21619 (Reactome) | |
TAB1 | Protein | Q15750 (Uniprot-TrEMBL) | |
TAB2 | Protein | Q9NYJ8 (Uniprot-TrEMBL) | |
TAB3 | Protein | Q8N5C8 (Uniprot-TrEMBL) | |
TEC,BTK,ITK, | Protein | REACT_165246 (Reactome) | |
TRAF6 | Protein | Q9Y4K3 (Uniprot-TrEMBL) | |
TRAF6 | Protein | Q9Y4K3 (Uniprot-TrEMBL) | |
UBE2N | Protein | P61088 (Uniprot-TrEMBL) | |
UBE2V1 | Protein | Q13404 (Uniprot-TrEMBL) | |
Ub-TRAF6 trimer bound to CBM complex | Complex | REACT_12752 (Reactome) | |
Ubc13 UBE2V1 | Complex | REACT_12995 (Reactome) | |
VAV1 | Protein | P15498 (Uniprot-TrEMBL) | |
VAV2 | Protein | P52735 (Uniprot-TrEMBL) | |
VAV3 | Protein | Q9UKW4 (Uniprot-TrEMBL) | |
VAV | Protein | REACT_21165 (Reactome) | |
Zn2+ | Metabolite | CHEBI:29105 (ChEBI) | |
p-10Y-LAT2 | Protein | Q9GZY6 (Uniprot-TrEMBL) | |
p-10Y-LAT2 | Protein | Q9GZY6 (Uniprot-TrEMBL) | |
p-10Y-NTAL
p-SHC1 GRB2 SOS GAB2 | Complex | REACT_164708 (Reactome) | |
p-10Y-NTAL
p-SHC1 GRB2 SOS p-3Y-GAB2 PI3K | Complex | REACT_164935 (Reactome) | |
p-10Y-NTAL
p-SHC1 GRB2 SOS p-3Y-GAB2 | Complex | REACT_164851 (Reactome) | |
p-10Y-NTAL
p-SHC1 GRB2 SOS | Complex | REACT_165062 (Reactome) | |
p-2S-cJUN p-2S,2T-cFOS | Complex | REACT_21707 (Reactome) | |
p-2Y-PAK | Protein | REACT_19490 (Reactome) | |
p-4Y-PLCG1 | Protein | P19174 (Uniprot-TrEMBL) | |
p-4Y-PLCG2 | Protein | P16885 (Uniprot-TrEMBL) | |
p-5Y-LAT
GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 PIP3 p-VAV RAC1-GTP PAK dimer | Complex | REACT_164313 (Reactome) | |
p-5Y-LAT
GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 PIP3 p-VAV RAC1-GTP | Complex | REACT_164894 (Reactome) | |
p-5Y-LAT
GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 PIP3 p-VAV | Complex | REACT_164523 (Reactome) | |
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS SLP76 PLCG | Complex | REACT_148415 (Reactome) | |
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS SLP76 | Complex | REACT_148283 (Reactome) | |
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV TEC kinases PIP3 | Complex | REACT_164096 (Reactome) | |
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV p-2Y-BTK/p-2Y-ITK PIP3 | Complex | REACT_164249 (Reactome) | |
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV p-2Y-TEC kinases | Complex | REACT_165277 (Reactome) | |
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV p-TEC kinases PIP3 | Complex | REACT_164842 (Reactome) | |
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV | Complex | REACT_164209 (Reactome) | |
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG | Complex | REACT_147980 (Reactome) | |
p-5Y-LAT
p-SHC1 GRB2 SOS1 | Complex | REACT_148348 (Reactome) | |
p-5Y-LAT-2 | Protein | O43561-2 (Uniprot-TrEMBL) | |
p-5Y-LAT-2 | Protein | O43561-2 (Uniprot-TrEMBL) | |
p-5Y-PKC-theta DAG | Complex | REACT_165187 (Reactome) | |
p-6Y-SYK | Protein | P43405 (Uniprot-TrEMBL) | |
p-BCL10 | Protein | O95999 (Uniprot-TrEMBL) | |
p-MAP2K4/p-MAP2K7 | Protein | REACT_21783 (Reactome) | |
p-MAPK8/9/10 | REACT_21549 (Reactome) | ||
p-MAPK8/9/10 | REACT_22035 (Reactome) | ||
p-S177,S181-IKBKB | Protein | O14920 (Uniprot-TrEMBL) | |
p-S177,S181-IKKB
IKKA NEMO | Complex | REACT_13373 (Reactome) | |
p-S177,S181-IKKB
IKKA pUb-NEMO | Complex | REACT_12853 (Reactome) | |
p-S243-NFATC2 | Protein | Q13469 (Uniprot-TrEMBL) | |
p-S257,T261-MAP2K4 | Protein | P45985 (Uniprot-TrEMBL) | |
p-S257-NFATC1 | Protein | O95644 (Uniprot-TrEMBL) | |
p-S265-NFATC3 | Protein | Q12968 (Uniprot-TrEMBL) | |
p-S271,T275-MAP2K7 | Protein | O14733 (Uniprot-TrEMBL) | |
p-S32,S36-NFKBIA | Protein | P25963 (Uniprot-TrEMBL) | |
p-S552,S645-CARD11 | Protein | Q9BXL7 (Uniprot-TrEMBL) | |
p-S552-CARD11 | Protein | Q9BXL7 (Uniprot-TrEMBL) | |
p-S63,S73-JUN | Protein | P05412 (Uniprot-TrEMBL) | |
p-S63,S73-JUN | Protein | P05412 (Uniprot-TrEMBL) | |
p-SHC1
GRB2 SOS | Complex | REACT_160377 (Reactome) | |
p-SYK/p-BTK | Complex | REACT_165606 (Reactome) | |
p-T325,T331,S362,S374-FOS | Protein | P01100 (Uniprot-TrEMBL) | |
p-T325,T331,S362,S374-FOS | Protein | P01100 (Uniprot-TrEMBL) | |
p-Y113,Y128,Y145-LCP2 | Protein | Q13094 (Uniprot-TrEMBL) | |
p-Y1400,Y1412-MAP3K1 | Protein | Q13233 (Uniprot-TrEMBL) | |
p-Y172-VAV2 | Protein | P52735 (Uniprot-TrEMBL) | |
p-Y173-VAV3 | Protein | Q9UKW4 (Uniprot-TrEMBL) | |
p-Y174-VAV1 | Protein | P15498 (Uniprot-TrEMBL) | |
p-Y239,Y240,Y317-SHC1-2 | Protein | P29353-2 (Uniprot-TrEMBL) | |
p-Y239,Y240,Y317-SHC1-2 | Protein | P29353-2 (Uniprot-TrEMBL) | |
p-Y396-LYN | Protein | P07948 (Uniprot-TrEMBL) | |
p-Y452,Y476,Y584-GAB2 | Protein | Q9UQC2 (Uniprot-TrEMBL) | |
p-Y90,T219,T538,S676,S695-PRKCQ | Protein | Q04759 (Uniprot-TrEMBL) | |
p-Y90-PKC-theta DAG | Complex | REACT_12758 (Reactome) | |
p-Y90-PRKCQ | Protein | Q04759 (Uniprot-TrEMBL) | |
p21 RAS GDP | Complex | REACT_2657 (Reactome) | |
p21 RAS GTP | Complex | REACT_4782 (Reactome) |
Annotated Interactions
View all... |
Source | Target | Type | Database reference | Comment |
---|---|---|---|---|
ADP | Arrow | REACT_12399 (Reactome) | ||
ADP | Arrow | REACT_163658 (Reactome) | ||
ADP | Arrow | REACT_163664 (Reactome) | ||
ADP | Arrow | REACT_163671 (Reactome) | ||
ADP | Arrow | REACT_163676 (Reactome) | ||
ADP | Arrow | REACT_163685 (Reactome) | ||
ADP | Arrow | REACT_163692 (Reactome) | ||
ADP | Arrow | REACT_163708 (Reactome) | ||
ADP | Arrow | REACT_163713 (Reactome) | ||
ADP | Arrow | REACT_163742 (Reactome) | ||
ADP | Arrow | REACT_163765 (Reactome) | ||
ADP | Arrow | REACT_163791 (Reactome) | ||
ADP | Arrow | REACT_163801 (Reactome) | ||
ADP | Arrow | REACT_163808 (Reactome) | ||
ADP | Arrow | REACT_163847 (Reactome) | ||
ADP | Arrow | REACT_163882 (Reactome) | ||
ADP | Arrow | REACT_163935 (Reactome) | ||
ADP | Arrow | REACT_163949 (Reactome) | ||
ADP | Arrow | REACT_163959 (Reactome) | ||
ADP | Arrow | REACT_163980 (Reactome) | ||
ADP | Arrow | REACT_163987 (Reactome) | ||
ADP | Arrow | REACT_163989 (Reactome) | ||
ADP | Arrow | REACT_163990 (Reactome) | ||
ADP | Arrow | REACT_21251 (Reactome) | ||
ADP | Arrow | REACT_6716 (Reactome) | ||
ADP | Arrow | REACT_6896 (Reactome) | ||
AMP | Arrow | REACT_163920 (Reactome) | ||
ATP | REACT_12399 (Reactome) | |||
ATP | REACT_163658 (Reactome) | |||
ATP | REACT_163664 (Reactome) | |||
ATP | REACT_163671 (Reactome) | |||
ATP | REACT_163676 (Reactome) | |||
ATP | REACT_163685 (Reactome) | |||
ATP | REACT_163692 (Reactome) | |||
ATP | REACT_163708 (Reactome) | |||
ATP | REACT_163713 (Reactome) | |||
ATP | REACT_163742 (Reactome) | |||
ATP | REACT_163765 (Reactome) | |||
ATP | REACT_163791 (Reactome) | |||
ATP | REACT_163801 (Reactome) | |||
ATP | REACT_163808 (Reactome) | |||
ATP | REACT_163847 (Reactome) | |||
ATP | REACT_163882 (Reactome) | |||
ATP | REACT_163920 (Reactome) | |||
ATP | REACT_163935 (Reactome) | |||
ATP | REACT_163949 (Reactome) | |||
ATP | REACT_163959 (Reactome) | |||
ATP | REACT_163980 (Reactome) | |||
ATP | REACT_163987 (Reactome) | |||
ATP | REACT_163989 (Reactome) | |||
ATP | REACT_163990 (Reactome) | |||
ATP | REACT_21251 (Reactome) | |||
ATP | REACT_6716 (Reactome) | |||
ATP | REACT_6896 (Reactome) | |||
Active Calmodulin | REACT_163756 (Reactome) | |||
Allergin
p-LYN p-FCERI IgE aggregate | Arrow | REACT_163959 (Reactome) | ||
Allergin
p-LYN p-FCERI IgE aggregate | REACT_163671 (Reactome) | |||
Allergin
p-LYN p-FCERI IgE aggregate | REACT_163716 (Reactome) | |||
Allergin | REACT_163837 (Reactome) | |||
BCL10 MALT1 | REACT_163941 (Reactome) | |||
BCL10 | REACT_163827 (Reactome) | |||
CALM1 | REACT_12602 (Reactome) | |||
CARD11 | REACT_163676 (Reactome) | |||
Ca2+ | REACT_12602 (Reactome) | |||
Ca2+ | REACT_163677 (Reactome) | |||
Ca2+ | REACT_163756 (Reactome) | |||
Calcineurin Calmodulin | REACT_163737 (Reactome) | |||
Calcineurin | REACT_163756 (Reactome) | |||
Clustered p
LYN p-FCERI IgE allergin SYK | REACT_163708 (Reactome) | |||
Clustered p
LYN p-FCERI IgE allergin p-6Y-SYK | Arrow | REACT_163708 (Reactome) | ||
Clustered p
LYN p-FCERI IgE allergin p-6Y-SYK | REACT_163742 (Reactome) | |||
Clustered p
LYN p-FCERI IgE allergin p-6Y-SYK | REACT_163791 (Reactome) | |||
Clustered p
LYN p-FCERI IgE allergin p-6Y-SYK | REACT_163808 (Reactome) | |||
Clustered p
LYN p-FCERI IgE allergin p-6Y-SYK | REACT_163847 (Reactome) | |||
Clustered p
LYN p-FCERI IgE allergin p-6Y-SYK | REACT_163935 (Reactome) | |||
DAG
p-5Y-PKC-theta CBM complex | REACT_163827 (Reactome) | |||
DAG
p-5Y-PKC-theta CBM oligomer TRAF6 oligomer | REACT_163920 (Reactome) | |||
DAG
p-5Y-PKC-theta CBM oligomer TRAF6 | REACT_163631 (Reactome) | |||
DAG
p-5Y-PKC-theta CBM oligomer oligo-K63-poly Ub-TRAF6 TAK1 TAB1 TAB2/3 | REACT_163664 (Reactome) | |||
DAG
p-5Y-PKC-theta CBM oligomer oligo-K63-poly Ub-TRAF6 activated TAK1 complex | Arrow | REACT_163664 (Reactome) | ||
DAG
p-5Y-PKC-theta CBM oligomer oligo-K63-poly Ub-TRAF6 activated TAK1 complex | REACT_163980 (Reactome) | |||
DAG
p-5Y-PKC-theta CBM oligomer oligo-K63-poly Ub-TRAF6 | Arrow | REACT_163920 (Reactome) | ||
DAG
p-5Y-PKC-theta CBM oligomer oligo-K63-poly Ub-TRAF6 | REACT_164005 (Reactome) | |||
DAG
p-5Y-PKC-theta CBM oligomer | REACT_163727 (Reactome) | |||
DAG
p-5Y-PKC-theta p-S552,S645-CARMA1 oligomer | REACT_163941 (Reactome) | |||
DAG
p-5Y-PKC-theta p-S552,S645-CARMA1 | Arrow | REACT_163676 (Reactome) | ||
DAG
p-5Y-PKC-theta p-S552,S645-CARMA1 | REACT_163673 (Reactome) | |||
DAGs | Arrow | REACT_163649 (Reactome) | ||
DAGs | REACT_163677 (Reactome) | |||
DAGs | REACT_163703 (Reactome) | |||
FCERI
IgE allergin aggregate | REACT_163959 (Reactome) | |||
FCERI IgE | REACT_163837 (Reactome) | |||
FOS | REACT_21251 (Reactome) | |||
GAB2 | REACT_163700 (Reactome) | |||
GADS SLP76 | REACT_147784 (Reactome) | |||
GDP | Arrow | REACT_147697 (Reactome) | ||
GDP | Arrow | REACT_163939 (Reactome) | ||
GRB2 SOS1 | REACT_163832 (Reactome) | |||
GTP | REACT_147697 (Reactome) | |||
GTP | REACT_163939 (Reactome) | |||
H2O | REACT_163649 (Reactome) | |||
H2O | REACT_163737 (Reactome) | |||
I | Arrow | REACT_12074 (Reactome) | ||
I | Arrow | REACT_163649 (Reactome) | ||
IKKA
IKKB NEMO | REACT_163980 (Reactome) | |||
IP3 receptor IP3 complex | REACT_12074 (Reactome) | |||
IP3 receptor homotetramer | REACT_12008 (Reactome) | |||
I | REACT_12008 (Reactome) | |||
IkB | REACT_12399 (Reactome) | |||
JUN | REACT_6716 (Reactome) | |||
K63polyUb | REACT_12553 (Reactome) | |||
K63polyUb | REACT_163920 (Reactome) | |||
LAT-2 | REACT_163808 (Reactome) | |||
LAT2 | REACT_163935 (Reactome) | |||
LYN | REACT_163801 (Reactome) | |||
MALT1 | REACT_163827 (Reactome) | |||
MAP2K4 | REACT_163987 (Reactome) | |||
MAP2K7 | REACT_163949 (Reactome) | |||
MAP3K1 | REACT_163685 (Reactome) | |||
MAPK8/9/10 | REACT_6896 (Reactome) | |||
NF-kB complex | Arrow | REACT_12399 (Reactome) | ||
NFAT
CaN CaM | Arrow | REACT_163737 (Reactome) | ||
PAK dimer | REACT_163979 (Reactome) | |||
PDPK1 | REACT_12641 (Reactome) | |||
PI3K | REACT_163929 (Reactome) | |||
PI | Arrow | REACT_163990 (Reactome) | ||
PIP3, PI | REACT_12641 (Reactome) | |||
PI | REACT_163649 (Reactome) | |||
PI | REACT_163692 (Reactome) | |||
PI | REACT_163700 (Reactome) | |||
PI | REACT_163881 (Reactome) | |||
PI | REACT_163990 (Reactome) | |||
PKC-theta | REACT_163671 (Reactome) | |||
PLC gamma1/2 | REACT_147817 (Reactome) | |||
PPi | Arrow | REACT_163920 (Reactome) | ||
PRKQC closed conformation | REACT_163703 (Reactome) | |||
Phospho-ERK dimer | REACT_21251 (Reactome) | |||
Phosphorylated NFATC1/2/3 | REACT_163737 (Reactome) | |||
Pi | Arrow | REACT_163737 (Reactome) | ||
RAC1-GDP | REACT_163939 (Reactome) | |||
REACT_12008 (Reactome) | The IP3 receptor (IP3R) is an IP3-gated calcium channel. It is a large, homotetrameric protein, similar to other calcium channel proteins such as ryanodine. The four subunits form a 'four-leafed clover' structure arranged around the central calcium channel. Binding of ligands such as IP3 results in conformational changes in the receptor's structure that leads to channel opening. | |||
REACT_12074 (Reactome) | IP3 promotes the release of intracellular calcium. | |||
REACT_12399 (Reactome) | NF-kB is sequestered in the cytosol of unstimulated cells through the interactions with a class of inhibitor proteins, called IkBs, which mask the nuclear localization signal (NLS) of NF-kB and prevent its nuclear translocation. A key event in NF-kB activation involves phosphorylation of IkB (at sites equivalent to Ser32 and Ser36 of IkB-alpha or Ser19 and Ser22 of IkB-beta) by IKK. The phosphorylated IkB-alpha is recognized by the E3 ligase complex and targeted for ubiquitin-mediated proteasomal degradation, releasing the NF-kB dimer p50/p65 into the nucleus to turn on target genes. (Karin & Ben-Neriah 2000) | |||
REACT_12553 (Reactome) | During the phosphorylation of the IKK beta, the regulatory subunit NEMO undergoes K-63-linked polyubiquitination. Ubiquitinated TRAF6 trimer, acts as a E3 ligase and induces this ubiquitination. The ubiquitin target sites in NEMO are not yet clearly identified. Studies of different NF-kB signaling pathways revealed several potential ubiquitination sites on NEMO (e.g., K285, K277, K309 and K399) (Fuminori et al. 2009). | |||
REACT_12602 (Reactome) | Upon increase in calcium concentration, calmodulin (CaM) is activated by binding to four calcium ions. | |||
REACT_12641 (Reactome) | PI3K activation results in recruitment of the serine/threonine kinase PDK1, (3-phosphoinositide-dependent kinase 1) to the plasma membrane where PDK1 subsequently phosphorylates and activates AKT. PDK1 with its PH domain binds to either PIP3 or PIP2 and is translocated to the plasma membrane. PDK1 seems to exist in an active, phosphorylated configuration under basal conditions (Vanhaesebroeck & Alessi 2000). | |||
REACT_147697 (Reactome) | GRB2-bound SOS promotes the formation of active GTP-bound RAS. This activates the mitogen-activated protein kinase (MAPK) cascade, leading to cell growth and differentiation. | |||
REACT_147717 (Reactome) | GRB2 is an adapter protein that contains a central SH2 domain flanked by N- and C-terminal SH3 domains. GRB2 acts downstream of receptor protein-tyrosine kinases and is involved in Ras and MAP kinase pathway activation by associating with the guanine exchange factor (GEF) SOS. GRB2 is constitutively bound to SOS through its SH3 domains, which interact with a proline-rich sequence in the C-terminal part of SOS (Chardin et al. 1993). Following phosphorylation of LAT, the GRB2:SOS complex binds to the phosphorylated tyrosines and is thereby translocated to the inner face of the plasma membrane where inactive RAS:GDP resides. The three distal tyrosines, Y171, Y191 and Y226 of LAT are responsible for GRB2 association (Balagopalan et al. 2010, Zhang et al. 2000). | |||
REACT_147784 (Reactome) | Gads/GRAP2 (GRB2-related adapter protein 2) is member of the GRB2 adaptor family with a central SH2 domain and linker region flanked by amino- and carboxy-terminal SH3 domains. SLP-76 associates constitutively via its central 20-amino acid proline-rich domain with the C-terminal SH3 domain of Gads, which recruits it to LAT following receptor stimulation. Upon LAT phosphorylation, Gads:SLP-76 complex principally binds to phosphorylated LAT tyrosine 191, with a reduced amount of binding to phosphorylated tyrosine 171 and no interaction with phosphorylated tyrosines 132 or 226 (Houtman et al. 2004, Zhu et al. 2003). Gads may promote cross-talk between the LAT and SLP-76 signaling complexes, thereby coupling membrane-proximal events to downstream signaling pathways (Liu et al. 1999). The LAT-Gads-SLP-76 complex creates a platform for the recruitment of multiple signaling molecules, including PLCgamma1, GRB2, NCK, Rho GEFs, VAV and the Tec-family kinases ITK and BTK (Liu et al. 1999 & 2001, Asada et al. 1999, Yablonski et al. 2001). | |||
REACT_147817 (Reactome) | The phospholipase PLC-gamma is an important mediator of TCR, FCERI and DAP12 signal transduction. PLC-gamma hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to produce inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) and in-turn promotes the Ca+2 influx and activation of NFAT. Activation of PLC-gamma1 entails the binding of PLC-gamma1 to both LAT and SLP-76 adapter proteins. The amino-terminal SH2 domain of PLC-gamma1 was shown to preferentially bind phosphorylated LAT Y132 with high affinity and no detectable binding to phosphorylated tyrosines 171, 191, and 226. PLC-gamma1 was also shown to bind the adapter protein SLP-76 indirectly through GADS, which is bound to LAT at Y171 and Y191. SH3 domain of PLC-gamma1 associates with the proline-rich region of SLP-76 (Yablonski et al. 2001). PLC-gamma1 associates with Gads/SLP-76 complex before binding to p-Y132 of LAT (Houtman et al. 2005). PLC-gamma1 association with LAT is stabilized by Gads/SLP-76 bound to LAT (Zhu et al.2003). Association of PLC-gamma to LAT and SLP-76 couples it to the kinases (Syk and Tec family kinase) required for tyrosine phosphorylation and activation of PLC-gamma. Mast cells express both PLC-gamma1 and PLC-gamma2 isoforms, which are phosphorylated by BTK/ITK and/or SYK. FCERI-dependent Ca2+ release requires the recruitment of PLC-gamma by SLP-76 and LAT. In mast cells, increased intracellular calcium triggers rapid release of preformed mediators, through a process of vesicle exocytosis, known as degranulation. Recruitment and activation of phospholipase C gamma (PLC-gamma) is involved in DAP12 signal transduction. Phosphorylation of multiple substrates including PLC-gamma1 has been observed in Ly49D/DAP12 triggered NK cells (McVicar et al. 1998). In myeloid cells, PLC-gamma2 is recruited and then phosphorylated upon activation of TREM2 and DAP12 (Peng et al. 2010). | |||
REACT_163631 (Reactome) | BCL10-MALT1 oligomers bind to TRAF6 and this inturn promotes the oligomerization of TRAF6 and activates its E3 ligase activity (Sun et al. 2004). | |||
REACT_163649 (Reactome) | Phosphoinositol 4,5-bisphosphate (PIP2) is cleaved in to two most important second messengers diacylglycerol (DAG) and Inositol 1,4,5-triphosphate (IP3) by phospholipase C (PLC). DAG remains within the membrane and activates protein kinase C (PKC) while IP3 leaves the cell membrane and binds to IP3 receptor that releases Ca2+ from endoplasmic reticulum (ER). | |||
REACT_163650 (Reactome) | Dephosphorylated NFAT-calcineurin (CaN) complex translocates to nucleus, where it activates transcription of several cytokine genes (e.g..IL2). | |||
REACT_163658 (Reactome) | Upon dimer disassociation PAK1 autophosphorylates in both cis- and trans- manner. Serine 144 (S144) in the GTPase-binding domain and threonine 423 (T423) in the activation loop are the target sites for autophosphorylation (Parrini et al. 2002). | |||
REACT_163664 (Reactome) | Binding of TAB2 and TAB3 to K63-linked polyubiquitin chains leads to the activation of TAK1 by an uncertain mechanism. Phosphorylation of TAK1 within the activation loop of the kinase is absolutely required for TAK1 activity. TAB1 is known to augment TAK1 catalytic activity by mediating spontaneous oligomerization and induces autophosphorylation of TAK1 (Kishimoto et al. 2000). The binding of TAB2/3 to polyubiquitinated TRAF6 may facilitate polyubiquitination of TAB2/3 by TRAF6 (Ishitani et al. 2003), which might result in conformational changes within the TAK1 complex that leads to the activation of TAK1. Some biochemical studies revealed that free K63 polyubiquitin chains, which are not conjugated to any cellular protein, can directly activate the TAK1 kinase complex (Xia et al. 2009). | |||
REACT_163671 (Reactome) | Raft localized PKC-theta is phosphorylated and is activated. Phosphorylation of both tyrosine and serine-threonine residues is important in the regulation of PKC function. Six phosphorylation sites have been identified on PKC-theta: Y90, T219, T538, S676, S685, and S695. Phosphorylation of Y90 positively regulates NF-AT and NF-kB activation in T-cells. In mast cells Src family members Src and LYN have been shown to be involved in phosphorylating Y90 (Wang et al. 2012, Liu et al. 2001). | |||
REACT_163673 (Reactome) | CARMA1 phosphorylation initiates its oligomerization and the coiled-coil (CC) domain of CARMA1 is hypothesized to mediate this clustering (Tanner et al. 2007). | |||
REACT_163676 (Reactome) | CARMA1 (CARD11/Caspase recruitment domain-containing protein 11), BCL10 (B-cell lymphoma/leukemia 10) and MALT1 (Mucosa-associated lymphoid tissue lymphoma translocation protein 1)/paracaspase have been identified as signaling components that act downstream of PKC-theta. CARMA1 is a scaffold protein and recruits BCL10, MALT1, PKC and TRAF6 to form a multi protein complex. CARMA1 exists in an inactive conformation in which the linker region binds to and blocks the accessibility of the CARD motif. Upon stimulation S552 and S645 linker residues are phosphorylated by PKC-theta and this may weaken this interaction, inducing an open conformation of CARMA1. Further phosphorylation studies have revealed other phosphorylation sites (S109, S551 and S555) that may also promote activation of CARMA1. Serene/threonine kinases PKC-beta, IKKbeta, HPK1 and CaMKII are involved in triggering CARMA1 activation (Thome et al. 2010, Rueda & Thome 2005). (only phosphorylated S552 and S645 are represented in this reaction) | |||
REACT_163677 (Reactome) | Ras guanyl nucleotide-releasing proteins (RasGRPs) are guanyl nucleotide exchange factors (GEFs) that activate Ras ultimately leading to MAPK activation. RasGRPs have a catalytic domain composed of Ras exchange motif (REM) and a CDC25 domain, an atypical pair of EF hands that bind calcium and a DAG-binding C1 domain. After PIP2 hydrolysis, RasGRPs are recruited to the plasma membrane by binding to DAG and calcium (Stone 2011, Liu et al. 2007). Upon T-cell activation RasGRP1 specifically interacts with and activates Ras on Golgi instead of the plasma membrane (Bivona et al. 2003). It remains to be determined whether activation of N-Ras by RasGRP1 in mast cells occurs in the Golgi or the plasma membrane (Liu et al. 2007). RasGRP4 is mast cell specific and is involved in the controls Ras activation. | |||
REACT_163685 (Reactome) | FCERI aggregation has been shown to activate JNK as well as protein kinases upstream of JNK, such as MEKK1 (Mitogen-activated protein kinase/ERK Kinase Kinase-1) and JNK kinase (JNKK). PAK has been shown to be the upstream kinase involved in the activation of MEKK1, however no direct phosphorylation of MEKK1 by PAK is observed. Two threonine residues at positions 1400 and 1412 (analogous to 1381 and 1393 in mouse) in the activation loop of MEKK1 between the kinase subdomains VII and VIII are essential for its catalytic activity. The catalytic domain of MEKK1 is able to autophosphorylate these residues, enhancing its own activity. | |||
REACT_163692 (Reactome) | Phosphorylation of VAV stimulates its GEF activity for RAC1, and thus it plays an important role in linking FCERI to the RAC1-JNK pathway. VAV exists in an auto-inhibitory state, folded in such a way as to inhibit the GEF activity of its DH domain. This folding is mediated through binding of tyrosines in the acidic domain to the DH domain and through binding of the calponin homology (CH) domain to the C1 region. Activation of VAV may involve three events which relieve this auto-inhibition: phosphorylation of tyrosines in the acidic domain causes them to be displaced from the DH domain; binding of a ligand to the CH domain may cause it to release the C1 domain; binding of the PI3K product PIP3 to the PH domain may alter its conformation (Aghazadeh et al. 2000). VAV is phosphorylated on tyrosine residue (Y174 in VAV1/172 in VAV2/173 in VAV3) in the acidic domain. This is mediated by SYK and Src-family tyrosine kinases (Deckert et al. 1996, Schuebel et al. 1998). Once activated, VAV is involved in the activation of RAC1, PAK1, MEK and ERK and cytokine production. | |||
REACT_163700 (Reactome) | NTAL cooperates with LAT in mast cells to activate PI3K pathway and cytokine production through Grb2-associated binding protein 2 (GAB2) (Gonzalez-Espinosa et al. 2003). FCERI aggregation induced translocation of a significant fraction of GAB2 from the cytosol to the plasma membrane by binding GRB2. Two of the proline-rich motifs in GAB2 are binding sites for the SH3 of GRB2. GAB2 is also recruited to plasma membrane by binding to phosphatidylinositol-3,4,5-trisphosphate (PIP3) with its plecstrin homology (PH) domain. GAB2 can be recruited to FCERI indirectly through GRB2 bound SHC1. SHC1 is recruited to the FCERI beta chain through its SH2 domain and becomes tyrosyl-phosphorylated. Phosphorylated SHC provides a docking site for the GRB2 and this in turn recruits GAB2 (Yu et al. 2006). GAB2 and PI3K are required for FCERI-induced granule translocation. | |||
REACT_163703 (Reactome) | DAG along with intracellular calcium signals cooperatively to activate PKCs, which then trigger other pathways such as the NF-kB pathway, ultimately leading to mast cell degranulation and cytokine production (Wu 2011). MCs express several Protein kinase C (PKC) isozymes and these kinases are involved in both the activation and termination of the degranulation process. PKC-delta is a negative regulator of FCERI mediated mast cell degranulation, whereas PKC-theta facilitates in degranulation (Leitges et al. 2002, Liu et al. 2001). In response to FCERI activation PKC-theta translocates to membrane by binding to DAG with its C1 domain. PKC-theta exists in two conformations closed/inactive and open/active state. In resting state, PKC-theta is autoinhibited where the pseudosubstrate sequence in the N-terminal regulatory region of PKC-theta forms intramolecular interaction with the substrate-binding region in the catalytic domain. This prevents the catalytic domain gaining access to substrates. The allosteric change of PKC-theta from closed to open state involves two important mechanisms: DAG binding to the C1 domains and autophosphorylation of T538 on the activation loop. Interaction with DAG induces conformational change resulting in the exposure of the activation loop of PKC-theta (Wang et al. 2012, Melowic et al. 2007). | |||
REACT_163708 (Reactome) | Multiple sites of phosphorylation are known to exist in SYK, which both regulate its activity and also serve as docking sites for other proteins. Some of these sites include Y131 of interdomain A, Y323, Y348, and Y352 of interdomain B, and Y525 and Y526 within the activation loop of the kinase domain and Y630 in the C-terminus (Zhang et al. 2002, Lupher et al. 1998, Furlong et al. 1997). Phosphorylation of these tyrosine residues disrupts autoinhibitory interactions and results in kinase activation even in the absence of phosphorylated ITAM tyrosines (Tsang et al. 2008). SYK is primarily phosphorylated by Src family kinases and this acts as an initiating trigger by generating few molecules of activated SYK which are then involved in major SYK autophosphorylation (Hillal et al. 1997). | |||
REACT_163712 (Reactome) | VAV an activator of RAC-GTPases, is redistributed to plasma membrane and is phosphorylated following engagement of FCERI. Phosphorylated SLP-76 tyrosines Y113 and Y128 (112Y and 128Y in mouse) provide binding sites for the SH2 domains of VAV. The binding of VAV to these phosphotyrosine residues may link SLP-76 to the Jun amino-terminal kinase (JNK) pathway and the actin cytoskeleton (Kettner et al. 2003). In addition to its known role as guanine nucleotide exchange factor (GEF), VAV also modulates cytokine production in mast cells. VAV1-deficient bone marrow-derived mast cells exhibited reduced degranulation and cytokine production and calcium release in addition of reduced activation of c-Jun NH2-terminal kinase 1 (JNK1), although tyrosine phosphorylation of FCERI, SYK and LAT was normal (Manetz et al. 2001, Arudchandran et al. 2000, Song et al. 1999). | |||
REACT_163713 (Reactome) | T219, T538 at the activation loop, S676 at the turn motif and S695 at the hydrophobic motif are autophosphorylated in cis-maanner. Posphorylation of T538 is critical for kinase activation and it stabilises the open active conformation. Some studies suggest the involvement of PDK1 (3-phosphoinositide-dependent protein kinase 1) and GLK kinases in the phosphorylation T538. | |||
REACT_163716 (Reactome) | Tyrosine phosphorylated ITAM in FCERI gamma subunit serves as docking site for SYK (spleen tyrosine kinases), whereas the beta-subunit ITAM has an extra tyrosine and is shorter than canonical ITAM which makes it unfit to bind SYK. Association of SYK to FCERI gamma-subunit disrupts the COOH-terminal-SH2 interdomain interaction of SYK causing a conformational change opening the molecule leading to its activation (Siraganian et al. 2010, de Castro et al. 2010). | |||
REACT_163727 (Reactome) | TRAF6 is a ubiquitin ligase that plays a central role in the IKK-dependent canonical NF-kB pathway. It is recruited to the CBM complex by binding to MALT1. The MALT1 C-terminal Ig domain and extension contain two binding motifs for TRAF6 (Noels et al 2007). After oligomerzation TRAF6, together with Ubc13/Uev1A, activates TAK1 and IKK. It also acts as an E3 ligase for MALT1 and mediates lysine 63-linked ubiquitination (Oeckinghaus et al. 2007). | |||
REACT_163737 (Reactome) | Nuclear factor of activated T-cells (NFAT) is a transcription factor which induces genes responsible for cytokine production, for cell-cell interactions etc. NFAT transcription activity is modulated by calcium and Calcineurin concentration. In resting cells NFAT is phosphorylated and resides in the cytoplasm. Phosphorylation sites are located in NFAT's regulatory domain in three different serine rich motifs, termed SRR1, SP2 and SP. Upon stimulation, these serine residues are dephosphorylated by calcineurin, that thought to cause exposure of nuclear localization signal sequences triggering translocation of the dephosphorylated NFAT-CaN complex to the nucleus. Among all the phosphorylation sites one of the site in SRR-2 motif is not susceptable to dephosphorylation by CaN (Takeuchi et al. 2007, Hogan et al. 2003). | |||
REACT_163742 (Reactome) | SLP-76 lacks intrinsic catalytic activity and acts as a scaffold, recruiting other proteins for correct localization during molecular signal transduction (Bogin et al. 2007). Activation of FCERI leads to tyrosine phosphorylation of SLP-76 (Gross et al. 1999). SLP-76 has three potential tyrosine phosphorylation sites within its amino terminus region: Y113, Y128, and Y145. Phosphorylation may be mediated by SYK, analogous to the role of ZAP-70 in phosphorylating T-cell SLP-76 (Bubeck-Wardenberg et al. 1996). | |||
REACT_163756 (Reactome) | Calcineurin (CaN), also called protein phosphatase 2B (PP2B), is a calcium/Calmodulin (CaM)-dependent serine/threonine protein phosphatase. It exists as a heterodimer consisting of CaM-binding catalytic subunit CaN A chain and a Ca+2 binding regulatory CaN B chain. At low calcium concentrations, CaN exists in an inactive state, where the autoinhibitory domain (AID) binds to the active-site cleft. Upon an increase in calcium concentration CaM binds to Ca+2 ions and gets activated. Active CaM binds to CaN regulatory domain (RD) and this causes release of the AID and activation of the phosphatase (Rumi-Masante et al. 2012). Binding of calcium to CaN B regulatory chain also causes a conformational change of the RD of CaN A chain (Yang & Klee 2000). | |||
REACT_163765 (Reactome) | Tyrosine phosphorylation of PLC-gamma enhances its catalytic activity. BTK and SYK are involved in the phosphorylation of PLC-gamma (PLCG). Phosphorylation of tyrosine residues 753, 759, 1197, and 1217 in PLCG2 and 771, 783, and 1254 in PLCG1 have been identified as BTK/SYK-dependent phosphorylation sites. | |||
REACT_163791 (Reactome) | SHC is an adapter protein that has been implicated in Ras activation. Mast cells express two isoforms of 46 and 52 kDa. Both isoforms of SHC have two domains, an N-terminal phosphotyrosine-binding (PTB) domain and a C-terminal SH2 domain that allows Shc to bind to proteins containing phosphorylated tyrosine residues. Following receptor stimulation, SHC is phosphorylated by Src kinases Syk on Y239, Y240 and Y317 (p56 isoform). Both phosphotyrosines Y239 and Y317 creates the binding site for the SH2 domain of GRB2. | |||
REACT_163801 (Reactome) | LYN localized in lipid rafts undergoes an intermolecular autophosphorylation at tyrosine 396. This residue is present in the activation loop, and its phosphorylation promotes LYN kinase activity. | |||
REACT_163808 (Reactome) | LAT is palmitoylated and membrane-associated adaptor protein. It rapidly becomes tyrosine-phosphorylated upon receptor engagement. LAT has nine conserved tyrosine residues of which five have been shown to undergo phosphorylation (Y127, Y132, Y171, Y191 and Y226). Src family kinases, SYK and ZAP-70 efficiently phosphorylate LAT on these tyrosine residues (Jiang & Cheng 2007, Paz et al. 2001). Phosphorylation of LAT creates binding sites for the Src homology 2 (SH2) domain proteins PLC-gamma1, GRB2 and GADS, which indirectly bind SOS, VAV, SLP-76 and ITK (Wange 2000). | |||
REACT_163827 (Reactome) | BCL10 and MALT1 proteins form high molecular weight oligomers and only these oligomeric forms can activate IKK in vitro (Sun et al. 2004). BCL10 proteins form homo-oligomers through CARD-CARD interactions whereas in MALT1 the tandem Ig-like domains naturally form oligomers with a tendency towards dimers and tetramers (Dong et al. 2006, Quiu & Dhe-Paganon 2011). These CBM oligomers provides the molecular platform, which can facilitate dimerization or serve as scaffolds on which proteases and kinases involved in NF-kB activation are assembled and activated. | |||
REACT_163832 (Reactome) | GRB2 is an adapter protein that contains a central SH2 domain flanked by N- and C-terminal SH3 domains. GRB2 acts downstream of receptor protein-tyrosine kinases and is involved in Ras and MAP kinase pathway activation by associating with the guanine exchange factor (GEF) SOS. GRB2 is constitutively bound to SOS through its SH3 domains, which interact with a proline-rich sequence in the C-terminal part of SOS (Chardin et al. 1993). GRB2-SOS complex binds to phosphotyrosine Y239 and Y317 of SHC1. SHC1 associates with the tyrosine-phosphorylated ITAMs of the FCERI beta-chain and can recruit SOS to membrane. SHC1 and SOS have also been described to associate with LAT via GRB2. Shc binding to Phospho-ITAMs (in vitro binding to phospho peptides) has never been linked to any biological function (activation) and is probably not relevant in a physiological setting. | |||
REACT_163837 (Reactome) | FCERI is primarily expressed on mast cells and basophils as a tetrameric complex comprising an IgE-binding alpha subunit, a signal amplifying membrane-tetraspanning beta subunit, and a disulfide-linked gamma chain dimer that provides the receptor its signaling competence (Blank & Rivera 2004). In the absence of an antigen or allergen, FCERI receptor binds to monomeric IgE antibodies, and thus the receptor adopts the antigenic specificity of the prevalent IgE repertoire (Garman et al. 2000). Mast cell activation is initiated when multivalent antigen crosslinks the IgE bound to the high-affinity FCERI, thereby aggregating FCERI (Siraganian 2003). Antigen driven aggregation of FCERI then elicits intracellular signals that result in mast cell exocytosis. | |||
REACT_163841 (Reactome) | Upon phosphorylation NATL/LAT2 recruits GRB2:SOS complex into the receptor-signaling complex. Residues Y95, Y118, Y136, Y193, Y233 are the putative GRB2-binding sites on NTAL (Iwaki et al. 2007). | |||
REACT_163847 (Reactome) | BTK/ITK are activated in a two step model. In the first step they are recruited to the membrane by binding to PIP3 or, alternatively with other binding partners like SLP-76. Once at the membrane SYK or Src-kinases in the vicinity phosphorylates Y551 (Y512 in ITK) in the activation loop of the catalytic domain of BTK to fully activate it (Rawlings et al. 1996, Park et al. 1996, Kawakami et al. 1994). | |||
REACT_163881 (Reactome) | Mast cells express four out of five Tec family members (i.e. BTK, ITK, RLK and TEC) and are activated upon cross-linking of FCERI. They are recruited to the membrane via the interaction of their PH domain with PtdIns(3,4,5)P3 phosphate and their SH2 domain with Y145 of SLP-76 (Kettner et al. 2003). BTK is more important for early response such as phosphorylation of PLC-gamma2 and Ca2+ mobilization, whereas ITK regulates the late responses such as changes in gene expression and cytokine secretion. BTK deficient mice have mild defects in degranulation and severe impairments in the production of proinflammatory cytokines upon FCERI cross-linking (Hata et al. 1998). ITK deficient mice have been reported to have reduced MC degranulation and responses to allergic asthma (Forssell et al. 2005). However, Bone marrow derived mast cells (BMMC) derived from ITK deficient mice display a normal degranulation response but secrete elevated level of cytokines (TNFa and IL-13) (Iyer & August 2008). TEC kinase is also one of the crucial regulators of murine mast cell function. TEC is phosphorylated and activated upon FCERI stimulation. TEC deficient bone marrow derived mast cells did not show any in vitro or in vivo defects in histamine release. However, the generation of the leukotriene LTC4 was severely impaired in the absence of TEC (Schmidt et al. 2009). | |||
REACT_163882 (Reactome) | GAB2 have multiple tyrosyl phosphorylation sites that are phosphorylated up on activation of FCERI. SYK is the major tyrosine kinase involved in GAB2 phosphorylation. FYN is also shown to contribute to GAB2 tyrosyl phosphorylation but it is not clear whether GAB2 is a direct substrate of FYN (Yu et al. 2006, Parravicini et al. 2002). GAB2 tyrosines (Y452, Y476 and Y584) in the YXXM motif can be the target phosphorylation sites for SYK/FYN kinases (Chan et al. 2010, Harir et al. 2007). | |||
REACT_163920 (Reactome) | TRAF6 possesses ubiquitin ligase activity and undergoes K-63-linked auto-ubiquitination after its oligomerization. In the first step, ubiquitin is activated by an E1 ubiquitin activating enzyme. The activated ubiquitin is transferred to a E2 conjugating enzyme (a heterodimer of proteins Ubc13 and Uev1A) forming the E2-Ub thioester. Finally, in the presence of ubiquitin-protein ligase E3 (TRAF6, a RING-domain E3), ubiquitin is attached to the target protein (TRAF6 on residue Lysine 124) through an isopeptide bond between the C-terminus of ubiquitin and the epsilon-amino group of a lysine residue in the target protein. In contrast to K-48-linked ubiquitination that leads to the proteosomal degradation of the target protein, K-63-linked polyubiquitin chains act as a scaffold to assemble protein kinase complexes and mediate their activation through proteosome-independent mechanisms. This K63 polyubiquitinated TRAF6 activates the TAK1 kinase complex. | |||
REACT_163925 (Reactome) | The released NF-kB transcription factor (p50/p65) with unmasked nuclear localization signal (NLS) then moves in to the nucleus. Once in the nucleus, NF-kB binds DNA and regulate the expression of genes encoding cytokines, cytokine receptors, and apoptotic regulators. | |||
REACT_163929 (Reactome) | Phosphorylated Y452, Y476, and Y584 of GAB2 binds p85 regulatory subunit of PI3K kinase, resulting in activation of PI3K pathway. PI3K is required for mast cell degranulation and anaphylaxis response but not for cytokine production or contact hypersensitivity (Nishida et al. 2011). Activated PI3K generates second messenger PtdInsP3 (PIP3) at the inner membrane, which provides docking sites for pleckstrin homology (PH) domains of PDK1, AKT and BTK. Activated AKT controls major downstream targets like mTORC1, FOXO3 and GSK3beta pathways that regulate mast cell growth, homeostasis, and cytokine production. BTK triggers PLCgamma2 activation, thereby inducing activation of the transcription factor NFAT and NF-kB. | |||
REACT_163935 (Reactome) | NTAL and LAT play complementary roles in the positive regulation of FCERI-mediated degranulation. Upon FCERI aggregation NTAL is phosphorylated by LYN, SYK and KIT on different tyrosines. Phosphorylated NTAL likely contributes to the activation of mast cells by providing docking sites for the recruitment of critical signaling molecules into the lipid raft. There are about ten tyrosines in LAT2 of which five tyrosines principally phosphorylated by SYK are recognised as putative GRB2-binding sites, being part of a YXN motif, whereas LYN and KIT phosphorylate both tyrosines contained in the YXN motifs as well as tyrosines outside of the YXN motifs (Iwaki et al. 2008). | |||
REACT_163939 (Reactome) | Rac1 exists in inactive state in the cytosol until the reception of extracellular signals by the cell. To be functional Rac1 is rapidly targeted to the plasma membrane upon cell stimulation. The main factors involved in this mobilisation are the Rac GEFs like VAV and phospholipids (PtdIns(4,5)P2, PtdIns(3,4,5) P3) and lipid rafts at the plasma membrane. VAV catalyses the disassociation of GDP from Rac1 by modifying the nucleotide-binding site such that GDP is released and subsequently replaced. The incoming GTP occupies the nucleotide binding site and finally displaces VAV from Rac1 (Bos et al. 2007, Bustelo et al. 2012). | |||
REACT_163941 (Reactome) | Phosphorylation of CARMA1 causes conformational change such that its CARD motif is exposed and is free to interact with BCL10 CARD motif. BCL10 constitutively associated with MALT1 and exists as a preformed complex in the cytoplasm. BCL10 and MALT1 have been identified as key positive regulators of FCERI-dependent NF-kB activation (Klemm et al. 2006). The resulting CARMA1-BCL10-MALT1 (CBM) complex may be stabilized by interactions between the CARMA1 coiled coil (CC) domain and a C-terminal MALT1 region that lacks the DD and first two Ig domains (Thome et al. 2010, Che et al. 2004). The CBM complex transmits activating signals that ultimately result in ubiquitination (Ub) and degradation of the NF-kB inhibitor, IkBa. | |||
REACT_163949 (Reactome) | MKK7 is activated by MEKK1 and the residues serine 271 and threonine 275 are the potential phosphorylation sites that are crucial for its kinase activity (phosphorylation sites are based on sequence alignment with MAP kinase kinase family members). | |||
REACT_163959 (Reactome) | Upon FCGRI-IgE aggregation, LYN kinase phosphorylates the tyrosine residues within the ITAM (immunoreceptor tyrosine-based activation motifs) of both the beta and gamma subunits. The detailed mechanism of the initial engagement of LYN kinase and FCERI is incompletely understood, but two different models have been proposed. One model postulates that a small fraction of LYN is constitutively bound to beta subunit of FCERI prior to activation. Aggregation of FCERI facilitates the transphosphorylation of one FCERI by LYN bound to a juxtaposed receptor (Vonakis et al. 1997, Draber & Draberova 2002). Alternative model postulates that LYN is observed in lipid rafts enriched in glycosphingolipids, cholesterol, and glycosylphosphatidylinositol-anchored proteins and upon aggregation, FCERI rapidly translocates into lipid rafts, where it is phosphorylated by LYN kinase. Either the association of LYN or FCERI or both with lipid rafts is important for initiating this phosphorylation process (Young et al. 2003, Kovarova et al. 2002, Draber & Draberova 2002). Beta subunit ITAM differs from canonical ITAMs in two ways; the spacing between the two canonical tyrosines harbours a third tyrosine, and it is one amino acid shorter than in canonical ITAMs, thus making it unfit to bind and recruit Syk. Among the three tyrosine residues (Y219, Y225 and Y229), Y219 may play a predominant role in beta chain function and LYN recruitment. Mutation of this tyrosine would decrease substantially LYN association and subsequent phosphorylation of Y225 and Y229. This would result in decreased gamma phosphorylation and decreased SYK recruitment and activation (On et al. 2004). | |||
REACT_163979 (Reactome) | PAK1 kinase is a member of serine/threonine protein kinase family and is widely believed as mediator between Cdc42 and Rac1 and the JNK signal transduction pathway. PAK1 is involved in regulating FCERI mediated mast cell degranulation via effects on calcium mobilisation and cytoskeletal changes (Allen et al. 2009). The conventional PAK family contains a N-terminal conserved Cdc42/Rac-interacting binding domain (CRIB) that overlaps a kinase inhibitory (KI) domain and a C-terminal catalytic domain. PAK1 molecules form trans-inhibited homodimers in which the N-terminal kinase inhibitory (KI) domain of one PAK1 molecule in the dimer binds and inhibits the C-terminal catalytic domain of the other. Isoprenylated Rac1/Cdc42-GTP localized to the membrane recruits PAK1 by binding to the N-terminal CRIB domain. Binding of activated Cdc42/Rac1, breaks the PAK1-dimer and removes the trans-inhibition and stimulates serine/threonine kinase activity of that allows autophosphorylation (Lu & Mayer 1999, Parrini et all. 2009, Zhao et al. 2005). | |||
REACT_163980 (Reactome) | In humans, the IkB kinase (IKK) complex serves as the master regulator for the activation of NF-kB by various stimuli. It contains two catalytic subunits, IKK alpha and IKK beta, and a regulatory subunit, IKKgamma/NEMO. The activation of IKK complex is dependent on the phosphorylation of IKK alpha/beta at its activation loop and the K63-linked ubiquitination of NEMO. This basic trimolecular complex is referred to as the IKK complex. IKK subunits have a N-term kinase domain a leucine zipper (LZ) motifs, a helix-loop-helix (HLH) and a C-ter NEMO binding domain (NBD). IKK catalytic subunits are dimerized through their LZ motifs. IKK beta is the major IKK catalytic subunit for NF-kB activation. Activated TAK1 phosphorylate IKK beta on S177 and S181 (S176 and S180 in IKK alpha) in the activation loop and thus activate the IKK kinase activity, leading to the IkB alpha phosphorylation and NF-kB activation. | |||
REACT_163987 (Reactome) | Activated MEKK1 then phosphorylates and activates SAPK/Erk kinase (SEK1), also known as MKK4 or Jun kinase kinase (JNKK) on serine and threonine residues at positions 257 and 261, respectively. | |||
REACT_163989 (Reactome) | After initial phosphorylation by SFK's, subsequently Y223 (Y180 in ITK and Y206 in TEC) in the SH3 domain of BTK is autophosphorylated, which may prevent inhibitory intramolecular interactions (Nore et al. 2003, Joseph et al. 2007, Park et al. 1996) | |||
REACT_163990 (Reactome) | PI3K catalyzes the conversion of phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-triphosphate (PIP3). This PIP3 acts as a membrane anchor for the downstream proteins like PDK1 and AKT. | |||
REACT_164005 (Reactome) | K-63 linked polyubiquitin (pUb) chain on TRAF6 provides a scaffold to recruit downstream effector molecules to activate NF-kB. Transforming growth factor beta-activated kinase 1 (TAK1) is a member of the mitogen-activated protein kinase (MAPK) kinase kinase family is shown to be an essential intermediate that transmits the upstream signals from the receptor complex to the downstream MAPKs and to the NF-kB pathway (Broglie et al. 2009). TAK1-binding protein 1 (TAB1), TAB2 and TAB3 constitutively bound to TAK1. TAB1 acts as the activation subunit of the TAK1 complex, aiding in the autophosphorylation of TAK1, whereas TAB2 and its homologue TAB3, act as a adaptors of TAK1 that facilitate the assembly of TAK1 complex to TRAF6. The highly conserved C-terminal zinc finger domain of TAB2 and TAB3 binds preferentially to the K-63-linked polyubiquitin chains on TRAF6 (Broglie et al. 2009, Besse et al. 2007). | |||
REACT_21251 (Reactome) | The Fos proteins(c-Fos, FosB, Fra1 and Fra2), which cannot homodimerize, form stable heterodimers with Jun proteins and thereby enhance their DNA binding activity. On activation of the MAPK pathway, Ser-374 of Fos is phosphorylated by ERK1/2 and Ser-362 is phosphorylated by RSK1/2, the latter kinases being activated by ERK1/2. If stimulation of the MAPK pathway is sufficiently sustained, ERK1/2 can dock on an upstream FTYP amino acid motif, called the DEF domain (docking site for ERKs, FXFP), and phosphorylate Thr-331 and Thr-325. Phosphorylation at specific sites enhances the transactivating potential of several AP-1 proteins, including Jun and Fos, without having any effect on their DNA binding activities. Thus, phosphorylation of Ser-362 and Ser-374 stabilizes c-Fos but has no demonstrated role in the control of transcriptional activity. On the contrary, phosphorylation of Thr-325 and Thr-331 enhances c-Fos transcriptional activity but has no demonstrated effect on protein turnover. | |||
REACT_21385 (Reactome) | c-Jun NH2 terminal kinase (JNK) plays a role in conveying signals from the cytosol to the nucleus, where they associate and activate their target transcription factors. | |||
REACT_21404 (Reactome) | The bZIP domains of Jun and Fos form an X-shaped -helical structure, which binds to the palindromic AP-1 site (TGAGTCA) (Glover and Harrison, 1995). | |||
REACT_6716 (Reactome) | JNK (c-Jun N-terminal Kinase) phosphorylates several transcription factors including c-Jun after translocation to the nucleus. | |||
REACT_6896 (Reactome) | Activated human JNK kinases (MKK4 and MKK7) phosphorylate Thr183 and Tyr185 residues in the characteristic Thr-Pro-Tyr phosphoacceptor loop of each JNK. JNK is differentially regulated by MKK4 and MKK7 depending on the stimulus. MKK7 is the primary activator of JNK in TNF, LPS, and PGN responses. However, TLR3 cascade requires both MKK4 and MKK7. Some studies reported that in three JNK isoforms tested MKK4 shows a striking preference for the tyrosine residue (Tyr-185), and MKK7 a striking preference for the threonine residue (Thr-183). | |||
RasGRPs | REACT_163677 (Reactome) | |||
SHC1-2 | REACT_163791 (Reactome) | |||
SYK/FYN | REACT_163882 (Reactome) | |||
SYK | REACT_163716 (Reactome) | |||
TAB1
TAB2/TAB3 TAK1 | REACT_164005 (Reactome) | |||
TEC,BTK,ITK, | REACT_163881 (Reactome) | |||
TRAF6 | REACT_163631 (Reactome) | |||
TRAF6 | REACT_163727 (Reactome) | |||
Ub-TRAF6 trimer bound to CBM complex | REACT_12553 (Reactome) | |||
Ubc13 UBE2V1 | Arrow | REACT_12553 (Reactome) | ||
Ubc13 UBE2V1 | Arrow | REACT_163920 (Reactome) | ||
Ubc13 UBE2V1 | REACT_12553 (Reactome) | |||
Ubc13 UBE2V1 | REACT_163920 (Reactome) | |||
VAV | REACT_163712 (Reactome) | |||
p-10Y-LAT2 | Arrow | REACT_163935 (Reactome) | ||
p-10Y-LAT2 | REACT_163841 (Reactome) | |||
p-10Y-NTAL
p-SHC1 GRB2 SOS GAB2 | REACT_163882 (Reactome) | |||
p-10Y-NTAL
p-SHC1 GRB2 SOS p-3Y-GAB2 PI3K | REACT_163990 (Reactome) | |||
p-10Y-NTAL
p-SHC1 GRB2 SOS p-3Y-GAB2 | Arrow | REACT_163882 (Reactome) | ||
p-10Y-NTAL
p-SHC1 GRB2 SOS p-3Y-GAB2 | REACT_163929 (Reactome) | |||
p-10Y-NTAL
p-SHC1 GRB2 SOS | REACT_163700 (Reactome) | |||
p-2Y-PAK | Arrow | REACT_163658 (Reactome) | ||
p-2Y-PAK | Arrow | REACT_163685 (Reactome) | ||
p-5Y-LAT
GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 PIP3 p-VAV RAC1-GTP PAK dimer | REACT_163658 (Reactome) | |||
p-5Y-LAT
GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 PIP3 p-VAV RAC1-GTP | Arrow | REACT_163658 (Reactome) | ||
p-5Y-LAT
GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 PIP3 p-VAV RAC1-GTP | Arrow | REACT_163939 (Reactome) | ||
p-5Y-LAT
GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 PIP3 p-VAV RAC1-GTP | REACT_163979 (Reactome) | |||
p-5Y-LAT
GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 PIP3 p-VAV | Arrow | REACT_163692 (Reactome) | ||
p-5Y-LAT
GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 PIP3 p-VAV | REACT_163939 (Reactome) | |||
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS SLP76 PLCG | REACT_163742 (Reactome) | |||
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS SLP76 | REACT_147817 (Reactome) | |||
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV TEC kinases PIP3 | REACT_163847 (Reactome) | |||
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV p-2Y-BTK/p-2Y-ITK PIP3 | Arrow | REACT_163765 (Reactome) | ||
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV p-2Y-BTK/p-2Y-ITK PIP3 | REACT_163649 (Reactome) | |||
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV p-2Y-TEC kinases | Arrow | REACT_163989 (Reactome) | ||
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV p-2Y-TEC kinases | REACT_163765 (Reactome) | |||
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV p-TEC kinases PIP3 | Arrow | REACT_163847 (Reactome) | ||
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV p-TEC kinases PIP3 | REACT_163989 (Reactome) | |||
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV | REACT_163692 (Reactome) | |||
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG1 VAV | REACT_163881 (Reactome) | |||
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG | Arrow | REACT_163742 (Reactome) | ||
p-5Y-LAT
p-SHC1 GRB2 SOS1 GADS p-Y113,Y128,Y145-SLP-76 PLCG | REACT_163712 (Reactome) | |||
p-5Y-LAT
p-SHC1 GRB2 SOS1 | REACT_147697 (Reactome) | |||
p-5Y-LAT
p-SHC1 GRB2 SOS1 | REACT_147784 (Reactome) | |||
p-5Y-LAT-2 | Arrow | REACT_163808 (Reactome) | ||
p-5Y-LAT-2 | REACT_147717 (Reactome) | |||
p-5Y-PKC-theta DAG | Arrow | REACT_163713 (Reactome) | ||
p-5Y-PKC-theta DAG | REACT_163676 (Reactome) | |||
p-MAP2K4/p-MAP2K7 | REACT_6896 (Reactome) | |||
p-MAPK8/9/10 | Arrow | REACT_6896 (Reactome) | ||
p-MAPK8/9/10 | REACT_6716 (Reactome) | |||
p-S177,S181-IKKB
IKKA NEMO | Arrow | REACT_163980 (Reactome) | ||
p-S177,S181-IKKB
IKKA NEMO | REACT_12553 (Reactome) | |||
p-S177,S181-IKKB
IKKA pUb-NEMO | Arrow | REACT_12553 (Reactome) | ||
p-S177,S181-IKKB
IKKA pUb-NEMO | REACT_12399 (Reactome) | |||
p-S257,T261-MAP2K4 | Arrow | REACT_163987 (Reactome) | ||
p-S271,T275-MAP2K7 | Arrow | REACT_163949 (Reactome) | ||
p-S32,S36-NFKBIA | Arrow | REACT_12399 (Reactome) | ||
p-S552,S645-CARD11 | REACT_163673 (Reactome) | |||
p-S63,S73-JUN | Arrow | REACT_6716 (Reactome) | ||
p-S63,S73-JUN | REACT_21404 (Reactome) | |||
p-SHC1
GRB2 SOS | REACT_147717 (Reactome) | |||
p-SHC1
GRB2 SOS | REACT_163841 (Reactome) | |||
p-SYK/p-BTK | REACT_163765 (Reactome) | |||
p-T325,T331,S362,S374-FOS | Arrow | REACT_21251 (Reactome) | ||
p-T325,T331,S362,S374-FOS | REACT_21404 (Reactome) | |||
p-Y1400,Y1412-MAP3K1 | Arrow | REACT_163685 (Reactome) | ||
p-Y1400,Y1412-MAP3K1 | REACT_163949 (Reactome) | |||
p-Y1400,Y1412-MAP3K1 | REACT_163987 (Reactome) | |||
p-Y239,Y240,Y317-SHC1-2 | Arrow | REACT_163791 (Reactome) | ||
p-Y239,Y240,Y317-SHC1-2 | REACT_163832 (Reactome) | |||
p-Y396-LYN | Arrow | REACT_163801 (Reactome) | ||
p-Y396-LYN | REACT_163959 (Reactome) | |||
p-Y90-PKC-theta DAG | Arrow | REACT_163671 (Reactome) | ||
p-Y90-PKC-theta DAG | REACT_163713 (Reactome) | |||
p21 RAS GDP | REACT_147697 (Reactome) | |||
p21 RAS GTP | Arrow | REACT_147697 (Reactome) |